WO2010136657A1 - Cosmetic and/or dermatological composition made from a combination of four plant extracts and the uses thereof - Google Patents

Cosmetic and/or dermatological composition made from a combination of four plant extracts and the uses thereof Download PDF

Info

Publication number
WO2010136657A1
WO2010136657A1 PCT/FR2009/000617 FR2009000617W WO2010136657A1 WO 2010136657 A1 WO2010136657 A1 WO 2010136657A1 FR 2009000617 W FR2009000617 W FR 2009000617W WO 2010136657 A1 WO2010136657 A1 WO 2010136657A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
plant extract
species
composition according
extract
Prior art date
Application number
PCT/FR2009/000617
Other languages
French (fr)
Inventor
Roger Renou
Isabelle Thuillier-Plessier
Marie-Laure Nicolas
Original Assignee
C.F.E.B. Sisley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C.F.E.B. Sisley filed Critical C.F.E.B. Sisley
Priority to PCT/FR2009/000617 priority Critical patent/WO2010136657A1/en
Publication of WO2010136657A1 publication Critical patent/WO2010136657A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]

Definitions

  • the present invention relates to cosmetic and / or dermatological compositions comprising a combination of four plant extracts.
  • the invention relates to a process for the cosmetic and / or dematological treatment of at least one keratin material, in particular the skin and the integuments, comprising the application to said material of a composition according to the invention, as well as the use of the combination of the four plant extracts as an anti-aging agent, especially as a repairing agent and / or protective agent in a cosmetic and / or dermatological composition.
  • references in brackets [] refer to the list of references at the end of the text.
  • the aging of the skin and superficial body growths in particular causes changes in the structure and / or cutaneous functions.
  • the main clinical signs of aging include the appearance of fine lines and deep wrinkles, the loss of firmness and radiance of the complexion, and the decrease in the hydration of the epidermis.
  • free radicals are mainly mentioned. These arise in part from molecular oxygen and may be induced by atmospheric pollutants and / or ultraviolet radiation.
  • Many compositions have already been developed in order to actively combat free radicals and the oxidation reactions they generate. There may be mentioned, for example, compositions based on vitamins A, C or E, those based on polyphenols (in particular of plant origin), or even compositions based on quinoline and its derivatives.
  • Amino acid compositions have also been used for their antioxidant action. These amino acids have the disadvantage of being very rapidly metabolized in cells and thus have a very low efficiency. To date, the known compositions do not solve the problems of aging due to inadequate repair and / or protection (s).
  • the present invention is specifically intended to meet this need by providing a cosmetic and / or dermatological composition
  • a cosmetic and / or dermatological composition comprising a combination of 4 plant extracts, said extracts being: (a) a plant extract of the species Oryza sativa L. or rice, (b) a plant extract of the species Triticum monococcum L. or small spelled,
  • the plant extract (a) can be advantageously obtained from the rice grains.
  • the plant extract (b) can be advantageously obtained from the seeds of small spelled.
  • the plant extract (c) is advantageously obtained from white willow leaves.
  • the plant extract (d) is advantageously obtained from calyxes of physalis.
  • the cosmetic and / or dermatological composition comprises a combination of 4 plant extracts, said extracts being: (a) a plant extract of the species Oryza sativa L. or rice obtained from grains of rice,
  • skin means the body which surrounds the body and which consists of several layers of tissue: - the epidermis (superficial layer),
  • the term skin applies in particular to the face, the lips, the eye contour, the neck, the body and / or the scalp.
  • the term “appendages” according to the invention encompasses all protective epidermal productions present on the surface of the body, in particular the hairs, eyelashes, eyebrows, nails and / or hair.
  • the combination of the 4 plant extracts according to the invention as well as the composition comprising it will make it possible to combat the aging of the skin by a repairing and / or protective action, in particular the aging of the face. , lips, eye area, neck, body and / or scalp.
  • aging of the skin is meant in particular any modification of the external appearance of the skin, such as, for example, the appearance of fine lines and deep wrinkles, the loss of firmness and radiance of the complexion and the decrease in the skin's appearance. hydration of the epidermis.
  • the combination of 4 plant extracts and a composition comprising it have a restorative action keratin materials and, in addition, a protective action against external aggression.
  • the use of this combination or a composition containing it, will allow keratin materials to be better repaired and better protected from stress that the environment produces.
  • aggression refers to the aggressions that the environment can produce. By way of example, mention may be made of aggressions such as pollution and UV radiation.
  • the plant extracts of the invention can be obtained by any extraction method known to those skilled in the art usually used in this field and adapted to the plant extracts of the invention. These methods include, for example, extraction processes with a solvent selected from the group consisting of water, at least one alcohol, at least one organic solvent, or their mixture; the process of extraction by steam distillation or hydro-distillation; the extraction process by mechanical process or by supercritical CO 2 , or by molecular distillation.
  • the extracts according to the invention are advantageously aqueous or hydroglycolic extracts.
  • the extract of calyxes of physalis can be obtained by solubilization of the calyxes of physalis, in particular reduced to powder, in a solvent, in particular chosen from water, alcohols comprising from 1 to 10 carbon atoms, and more particularly ethanol, as well as a mixture of these solvents.
  • a solvent in particular chosen from water, alcohols comprising from 1 to 10 carbon atoms, and more particularly ethanol, as well as a mixture of these solvents.
  • the chalices of physalis are solubilized in water.
  • the solution of calyxes of physalis can be treated enzymatically, in particular by at least one protease, in particular at a temperature ranging from 15 to 45 ° C.
  • the protease may be for example an endo- and / or exo-peptidase of plant origin (papain, bromelain).
  • the soluble and insoluble phases can be separated, for example by filtration, decantation or centrifugation or a combination of these means.
  • the dispersion or solution of calyxes of physalis may undergo a heat treatment, in particular intended to inactivate the enzymes used.
  • a heat treatment in particular intended to inactivate the enzymes used.
  • the solution can be concentrated, in particular by evaporation.
  • the sterilization can be carried out by sterilizing filtration, for example by passage over a microporous membrane.
  • the calyx extract of physalis is an aqueous extract.
  • 1 part by weight of chalices of dry physalis give from 1.5 to 3 parts by weight, and in particular from 2 to 2.5 parts by weight of calyx extract of Physalis.
  • the calyx extract of physalis can comprise a solids content ranging from 30 to 100 g / l, in particular from 40 to 80 g / l, and in particular from 45 to 65 g / l.
  • the calyx extract of physalis can include phenolic compounds.
  • phenolic compounds present in the physalis calyx extract may comprise: hydroxycinnamic compounds, especially in a content ranging from 60 to 99% by weight, in particular from 80 to 98% by weight, or even from 90 to 96% by weight; weight relative to the total weight of polyphenols, and flavones especially in a content ranging from 0.1 to 20% by weight, in particular from 1 to 10% by weight, or even 2.5 to 7% by weight relative to total weight of polyphenols.
  • the hydroxycinnamic compounds present in the physalis calyx extract may comprise ferulic acid, especially in a content ranging from 25 to 75% by weight, in particular from 30 to 70% by weight, or even from 40 to 60% by weight. weight relative to the total weight of hydroxycinnamic compounds.
  • the calyx extract of physalis can comprise a polyphenol content, expressed in gallic acid, ranging from 0.1 to 5 g / l, in particular from 0.25 to 2.5 g / l, and in particular from 0.5 at 1, 2 g / l.
  • the composition according to the invention may comprise an extract content of Physalis alkekengi L. or alkenkene, ranging from 0.1 to 20% by weight, in particular from 0.2 to 10% by weight, and in particular from 0.3 to 5% by weight, relative to the total weight of the composition.
  • the other plant extracts of the combination of the invention can be obtained by a process as described in [1] and [2], or else, for example, by extraction using a solvent chosen from water, alcohol, a glycol, glycerin, acetone or a mixture of these solvents.
  • it may be an aqueous or a glycolic extract.
  • the extract is filtered.
  • An extract of Oryza sativa L. or rice, usable according to the invention can also be obtained from the company ISP-VINCIENCE, marketed under the trade name ORSIRTINE®.
  • composition according to the invention may comprise an extract content of Oryza sativa L or rice, ranging from 0.1% to 20% by weight, in particular from 0.2% to 10% by weight, and in particular from 0.5% by weight. at 5% by weight, relative to the total weight of the composition.
  • Triticum monococcum L or small spelled, usable according to the invention can also be obtained from the company ISP - VINCIENCE under the trade name PHYTOQUINTESCINE ®
  • composition according to the invention may comprise an extract content of Triticum monococcum L. or small spelled ranging from 0.1 to 20% by weight, especially from 0.2 to 10% by weight, and in particular from 0.5 to 5% by weight, relative to the total weight of the composition.
  • An extract of Salix alba L. White willow or used according to the invention may also be obtained from the company Silab under the trade name ASTRESSYL ® GR.
  • composition according to the invention may comprise an extract content of Salix alba L. or white willow ranging from 0.1 to 20% by weight, especially from 0.2 to 10% by weight, and in particular from 0.5 at 5% by weight, relative to the total weight of the composition.
  • the refractive index of an airborne medium is equal to the ratio of the sinus of the angle of incidence of a light ray in the air to the sine of the refracted angle of refraction. in the medium in question.
  • the refractive index is determined at 20 ° C. ⁇ 1 ° C. and is based on the sodium D line.
  • the dry extract represents the percentage of all the substances which do not volatilize with respect to the substances of the test portion of a sample.
  • the substance to be examined is placed in an oven at 105 ° C ⁇ 2 ° C for 12h ⁇ 2h.
  • Specific equipment oven at 105 0 ⁇ 2 ° C Memmert type or equivalent.
  • Method Take a tare flask, remove all traces of water by putting it at least 1 hour in an oven at 105 0 C and then in the desiccator the time of cooling. Make the bottle tare. Introduce approximately exactly 1g of the substance to be examined. Put in the oven at 105 0 ⁇ 2 ° C. After 12 hours (more or less 2 hours) remove the bottle and cool in the desiccator. Weigh the vial and calculate the mass of the substance being examined.
  • the Hydranal reagent is a solution of iodine (I 2 ) and sulfur dioxide (SO 2 ) in methanol (CH 3 OH). In the absence of water the reagent is stable, but in the presence of water, the sulfur dioxide is oxidized to trioxide or sulfuric acid by the iodine following the reaction: I 2 + SO 2 + 2H 2 O -> 2Hl + H 2 SO 4
  • Iodine and sulfur dioxide react with each other in the presence of water. As long as the solution contains water, the polarization of the cathode is opposed to the passage of the current; the drop of reagent titrant in excess brings free iodine which causes depolarization of the cathode and allows the passage of a current detected by a suitable electrical device.
  • composition according to the invention may be in any form known to those skilled in the field of cosmetics and / or dermatology for application to the skin, in particular the face, the lips, the eye contour, the neck, body and / or scalp and / or integuments, in particular hairs, eyelashes, eyebrows, nails and / or hair.
  • the composition according to the invention may be in the form of: an aqueous or alcoholic solution or suspension of the lotion or serum type, an emulsion of liquid or semi-liquid consistency of milk type, obtained by dispersion of a fatty phase in an aqueous phase (oil in water emulsion: O / W) or conversely (water in oil: EJH), an O / W or W / O cream emulsion, a gel, or a gel-emulsion, a mask, - an anhydrous product such as an oil, a balm, a powder.
  • the compositions of the invention may also be in the form of a foam or in a form suitable for aerosol also comprising a propellant under pressure.
  • the composition according to the invention is a composition for the skin, in particular for the care of the skin, in particular the face, the lips, the eye contour, the neck, the body and / or scalp.
  • composition may then be, for example, an O / W or W / O emulsion, of the milk or cream type.
  • the composition according to the invention when it is in the form of an O / W emulsion, comprises an aqueous phase which forms the continuous phase of the composition.
  • the aqueous phase can then essentially or exclusively include water. It may also comprise a mixture of water and organic solvents miscible with water (miscibility in water greater than 50% by weight at 25 0 C) such as alcohols having 2 to 5 carbon atoms chosen from the group comprising ethanol, isopropanol, tert-butanol and n-butanol, and alkylene glycols having 2 to 8 carbon atoms selected from the group consisting of propylene glycol and its derivatives, 1,3-butylene glycol, pentylene glycol, dipropylene glycol, ketones having 3 to 4 carbon atoms and polyols selected from the group consisting of glycerine.
  • organic solvents miscible with water such as alcohols having 2 to 5 carbon atoms chosen from the group comprising ethanol, isopropanol, tert-butanol and n-butanol, and alkylene glycols having 2 to 8 carbon atoms selected from the group consist
  • the aqueous phase (water and optionally water-miscible organic solvents) may be present in a content ranging from 1 to 95% by weight, in particular ranging from 10 to 90% by weight, and in particular ranging from 60 to 85% by weight. by weight, relative to the total weight of the composition.
  • the aqueous phase may further comprise gelling agents / stabilizers such as gums, synthetic polymers and their derivatives.
  • gelling agents / stabilizers such as gums, synthetic polymers and their derivatives.
  • a fatty or oily phase is dispersed in said aqueous phase.
  • This fatty or oily phase is generally present in a smaller amount, for example ranging from 5 to 50% by weight, in particular from 15 to 40% by weight, relative to the total weight of the composition.
  • the fatty or oily phase may comprise a fatty substance which is liquid at ambient temperature (20 ° C.) and at atmospheric pressure. This liquid fatty substance may be chosen from volatile oils or not.
  • the oily or oily phase may also comprise a solid fatty substance at ambient temperature (20 ° C.) and at atmospheric pressure such as waxes, pasty fatty substances, gums and mixtures thereof.
  • the fatty phase may also contain gelling agents / stabilizers and structuring oils of organic nature and / or lipophilic organic solvents.
  • the composition according to the invention when in the W / O emulsion form, comprises a fatty or oily phase which forms the continuous phase of the composition.
  • the fatty phase may comprise at least one fatty substance that is liquid at room temperature (25 ° C.) and at atmospheric pressure and / or at least one solid substance that is solid at ambient temperature and at atmospheric pressure, such as waxes, pasty fatty substances, gums and mixtures thereof.
  • the fatty phase may also contain gelling agents / stabilizers and structuring oils of organic nature and / or lipophilic organic solvents.
  • the fatty phase may include, but is not limited to, a fatty-liquid-to-liquid-at-the-least volatile or nonvolatile oil or mixture thereof.
  • volatile oil means any oil capable of evaporating on contact with the skin in less than one hour, at ambient temperature (20 ° C.) and atmospheric pressure.
  • the volatile compounds of the invention may be volatile cosmetic oils which are liquid at ambient temperature and have a non-zero vapor pressure at ambient temperature and atmospheric pressure, in particular ranging from 0.01 to 300 mmHg (1.33 Pa to 40,000). Pa) and in particular greater than 0.3 mm Hg (40 Pa).
  • non-volatile oil is meant an oil remaining on the skin at ambient temperature (20 ° C.) and atmospheric pressure for at least several hours and having in particular a vapor pressure of less than 0.01 mmHg (1.33 Pa). ).
  • volatile or non-volatile oils may be hydrocarbon oils, in particular of plant origin, silicone oils, or mixtures thereof.
  • hydrocarbon-based oil means an oil containing mainly hydrogen and carbon atoms and optionally oxygen, nitrogen, sulfur and / or phosphorus atoms.
  • the volatile hydrocarbon oils may be chosen from hydrocarbon-based oils containing from 8 to 16 carbon atoms, and in particular C8-C16 branched alkanes, such as C8-C16 isoalkanes of petroleum origin (also called isoparaffins), such as isododecane (also known as 2,2,4,4,6-pentamethylheptane), isodecane, isohexadecane, and for example the oils sold under the trade names Isopar or Permethyl ® ®, branched esters, C8- C16 such as isohexyl neopentanoate, and mixtures thereof.
  • C8-C16 branched alkanes such as C8-C16 isoalkanes of petroleum origin (also called isoparaffins), such as isododecane (also known as 2,2,4,4,6-pentamethylheptane), isodecane, isohexadecane, and for example the oils sold under the
  • Volatile silicones such as, for example, volatile linear or cyclic silicone oils, especially those with less than or equal to 8 centistokes (8 ⁇ 10 -6 m 2 / s), are used as volatile oils. in particular from 2 to 7 silicon atoms, these silicones optionally comprising alkyl or alkoxy groups having from 1 to 10 carbon atoms.
  • volatile silicone oil that may be used in the invention, mention may be made in particular of octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane and dodecamethylcyclohexasiloxane.
  • heptamethyl hexyltrisiloxane heptamethyloctyltrisiloxane, hexamethyl disiloxane, octamethyltrisiloxane, decamethyltetrasiloxane, dodecamethylpentasiloxane and mixtures thereof.
  • composition according to the invention comprises a volatile oil
  • the latter may be present in a content ranging from 0.1 to 98% by weight, in particular from 1 to 65% by weight, and in particular from 2 to 50% by weight. , relative to the total weight of the composition.
  • the non-volatile oils may in particular be chosen from fluorinated hydrocarbon oils which may be fluorinated and / or non-volatile silicone oils.
  • non-volatile hydrocarbon oil mention may notably be made of:
  • hydrocarbon oils of vegetable origin such as squalane
  • hydrocarbon-based oils of plant origin such as triglycerides consisting of esters of fatty acids and of glycerol, the fatty acids of which may have various chain lengths of C4 to C24, the latter may be linear or branched, saturated or unsaturated; ; these oils include wheat germ, sunflower, plum, grape seed, sesame, maize, apricot, castor, avocado, olive, soya, sweet almond oil palm, rapeseed, cotton, hazelnut, macadamia, sesame, pumpkin, rapeseed, blackcurrant, evening primrose, safflower, muscat rose; shea butter; or triglycerides of caprylic / capric acids such as those sold by the company Stéarineries Dubois; or alternatively hydrogenated triglycerides of vegetable origin, for example derivatives of hydrogenated castor oil, synthetic ethers having from 10 to 40 carbon atoms,
  • linear or branched hydrocarbons of mineral or synthetic origin such as petroleum jelly, polydecenes, hydrogenated polyisobutene such as Parleam, squalane and their mixtures; synthetic esters, such as the oils of formula R 1 COOR 2 in which R 1 represents the remainder of a linear or branched fatty acid having 1 to 40 carbon atoms and R 2 represents a particularly branched hydrocarbon chain containing from 1 to 40 carbon atoms, provided that R 1 + R 2 is greater than or equal to 10 carbon atoms, for example Purcellin oil.
  • R 1 COOR 2 in which R 1 represents the remainder of a linear or branched fatty acid having 1 to 40 carbon atoms and R 2 represents a particularly branched hydrocarbon chain containing from 1 to 40 carbon atoms, provided that R 1 + R 2 is greater than or equal to 10 carbon atoms, for example Purcellin oil.
  • keto stearyl octanoate isopropyl myristate, isopropyl palmitate, benzoates of alcohols having 2 to 5 carbon atoms, hexyl laurate, diisopropyl adipate, isononanoate isononyl, 2-ethylhexyl palmitate, isostearyl isostearate, heptanoates, octanoates, decanoates or ricinoleates of alcohols or polyalcohols such as propylene glycol dioctanoate; hydroxylated esters such as isostearyl lactate, diisostearyl malate; polyol esters and pentaerythritol esters,
  • liquids with a branched and / or unsaturated carbon chain having from 12 to 26 carbon atoms such as octyl dodecanol, isostearyl alcohol, oleic alcohol, 2-hexyldecanol or 2-butyloctanol, and 2 undecylpentadecanol,
  • higher fatty acids such as oleic acid, linoleic acid, linolenic acid and mixtures thereof.
  • the non-volatile silicone oils that may be used in the composition according to the invention may be non-volatile polydimethylsiloxanes (PDMS), polydimethylsiloxanes comprising pendant alkyl or alkoxy groups and / or silicone chain ends, groups each having from 2 to 24 atoms. carbon, phenyl silicones such as phenyl trimethicones, phenyl dimethicones, phenyl trimethyloxy diphenylsiloxanes, diphenyl dimethicones, diphenyl methyldiphenyl trisiloxanes. and 2-phenylethyltrimethylsiloxysilicates.
  • PDMS non-volatile polydimethylsiloxanes
  • phenyl silicones such as phenyl trimethicones, phenyl dimethicones, phenyl trimethyloxy diphenylsiloxanes, diphenyl dimethicones, diphenyl methyldiphen
  • the non-volatile oils may be present in the composition according to the invention in a content ranging from 0.01 to 90% by weight, especially from 0.1% to 85% by weight, and in particular from 1% to 70% by weight. weight, relative to the total weight of the composition. More generally, the fatty substance which is liquid at ambient temperature and at atmospheric pressure may be present in a proportion of from 0.01 to 90% by weight and in particular from 0.1 to 80% by weight, relative to the weight of the fatty phase. Regarding solid fat at room temperature
  • This solid fatty substance may be present in a proportion of from 0.01% to 50% by weight, in particular from 0.1% to 40% by weight and in particular from 0.2% to 30% by weight, relative to the total weight of the composition. .
  • composition according to the invention may comprise at least one pasty fatty compound at ambient temperature (approximately 20 ° C.).
  • pasty fatty substance means fatty substances capable of melting in contact with the skin, for example bodies having a melting point ranging from 25 ° to 45 ° C.
  • these fatty substances may be hydrocarbon compounds, optionally of polymeric type; they can also be chosen from silicone compounds; they may also be in the form of a mixture of hydrocarbon compounds and / or silicone.
  • hydrocarbon-based pasty compounds mainly containing carbon and hydrogen atoms and optionally ester groups
  • silicone pasty fatty substances such as polydimethylsiloxanes (PDMS) of high molecular weight and in particular those having pendent chains of the alkyl or alkoxy type having from 8 to 24 carbon atoms, and a melting point of 20- 55 0 C, such as stearyl dimethicone, in particular that sold by Dow Corning under the trade name DC 2503 ® Cosmetic Wax.
  • the pasty fatty substance may be present in the composition according to the invention in a content ranging from 0.01 to 50% by weight, in particular ranging from 0.1 to 45% by weight, and in particular ranging from 0.2 to 30% by weight relative to the total weight of the composition.
  • composition according to the invention may further comprise a wax.
  • the wax may be solid at ambient temperature (20 ° C.), with reversible solid / liquid state change, having a melting point of greater than 30 ° C. and up to 200 ° C., a hardness of greater than 0.5 MPa and having in the solid state an anisotropic crystalline organization.
  • It can be hydrocarbon, fluorinated and / or silicone and be of animal, vegetable, mineral or synthetic origin. It may be chosen for example from beeswax, carnauba wax, candelilla wax, paraffin waxes, hydrogenated castor oil, silicone waxes, and microcrystalline waxes and mixtures thereof.
  • the wax may be present in the composition according to the invention in a content ranging from 0.01 to 50% by weight, in particular from 0.1 to 30% by weight, and especially from 0.2 to 20% by weight, relative to the total weight of the composition.
  • composition according to the invention may further contain emulsifying surfactants present in particular in a proportion ranging from
  • composition 0.1 to 30% by weight, and in particular 1 to 15% by weight relative to the total weight of the composition.
  • surfactants may be chosen from anionic, cationic, amphoteric or nonionic surfactants.
  • the surfactants used in the composition according to the invention are chosen from nonionic surfactants such as derivatives of fatty acids and fatty alcohols and glycolized derivatives.
  • the composition of the invention may further comprise an additional particulate phase which may be present in a proportion of from 0.01 to 40% by weight, in particular from 0.01 to 30% by weight and in particular from 0.05 to 20% by weight. by weight, relative to the total weight of the composition. It may in particular comprise at least one pigment and / or at least one nacre and / or at least one additional filler used in the cosmetic compositions.
  • pigments it is necessary to understand white or colored particles, mineral or organic, insoluble in the liquid hydrophilic phase, intended to color and / or opacify the composition.
  • nacres it is necessary to understand iridescent and / or colored particles, obtained mainly by synthesis.
  • charges it is necessary to include colorless or white, mineral or synthetic, lamellar or non-lamellar particles.
  • inorganic pigments that may be used in the invention, mention may be made of titanium, zirconium or cerium oxides as well as oxides of zinc, iron or chromium.
  • organic pigments that can be used in the invention, particular mention may be made of D & C type pigments and lacquers on a barium, strontium, calcium or aluminum support.
  • the quantity and / or the choice of these pigments are generally adjusted taking into account the destination of the composition.
  • the nacres may be present in the composition in a proportion of from 0.01 to 25% by weight, especially from 0.01 to 15% by weight, and in particular from 0.02 to 5% by weight relative to the total weight of the composition. composition.
  • Nacres can be used as mica-titanium (mica coated with titanium dioxide), colored nacres such as mica with iron oxides.
  • the additional fillers may be present in a proportion of from 0.01 to 40% by weight, in particular from 0.01 to 30% by weight, and in particular from 0.02 to 20% by weight relative to the total weight of the composition. It may in particular be possibly spherical fillers such as, for example, talc, zinc stearate, mica, kaolin, polyamide (Nylon ® ) powders (Orgasol ® ), polyethylene powders, polyvinyl powders, methyl methacrylate (methyl methacrylate crosspolymer), tetrafluoroethylene polymer powders (Teflon ®), starch, boron nitride, polymer microspheres such as those of polyvinylidene chloride / acrylonitrile, for instance Expancel ®, copolymers of acrylic (Polytrap ® from Dow Corning) and silicone resin microbeads (Tospearls ® from Toshiba, for example), and organopolysiloxane elasto
  • the composition may also comprise water-soluble or fat-soluble dyes in a content ranging from 0.01 to 6% by weight, especially ranging from 0.01 to 3% by weight relative to the total weight of the composition.
  • Liposoluble dyes are, for example, Sudan red, DC Red 17, DC Green 6, carotene, soybean oil, Sudan brown, DC Yellow 11, DC Violet 2, DC orange 5, and yellow quinoline.
  • the water-soluble dyes are, for example, beet juice and FD & C blue i.
  • composition according to the invention may, moreover, comprise all the ingredients conventionally used in the fields concerned and more particularly in the cosmetic and / or dermatological field.
  • These ingredients are in particular chosen from vitamins and derivatives, antioxidants, thickeners, trace elements, softeners, sequestering agents, perfumes, alkalizing or acidifying agents, preservatives, UV filters, essential oils. ⁇ hydrophilic or lipophilic active agents and mixtures thereof.
  • the amounts of these various ingredients are those conventionally used in the fields concerned and for example from 0.01 to 20% of the total weight of the composition.
  • the person skilled in the art will take care to choose this or these optional complementary compounds, and / or their amount, such that the advantageous properties of the composition according to the invention are not, or not substantially impaired by the addition considered.
  • composition according to the invention can be obtained according to the preparation methods conventionally used in cosmetics and / or in dermatology.
  • composition according to the invention is in the form of an O / W emulsion. It can also be in the form of a product cast in a stick, in a pot or in a dish such as lipsticks or lip balms, cast foundations, concealer products, "correctors"
  • composition according to the invention may especially be a care composition for the skin, in particular the face, the lips, the eye contour, the neck, the body and / or the scalp and / or the dander, in particular the hairs. , eyelashes, eyebrows, nails and / or hair.
  • Said composition may optionally comprise at least one photoprotective system.
  • composition according to the invention may also be a sunscreen composition, in particular for the skin and / or integuments, comprising a photoprotective system.
  • the photoprotective system may be present in a content ranging from 0.1 to 40% by weight, in particular from 0.5 to 30% by weight, or even from 1 to 20% by weight, relative to the total weight. of the composition.
  • This photoprotective system may comprise at least one hydrophilic organic filter, at least one lipophilic organic filter and / or at least one mineral pigment.
  • the filters may be chosen from N 1 N, N-trimethyl [(oxo-2-bornborn-3-yl) methyl] -4-anilinium methyl sulfate; homosalate (INN); oxybenzone (INN); 2-phenylbenzimidazol sulfonic acid and its potassium, sodium and triethanolamine salts; 3,3 '- (1,4-phenylenedimethylene) bis (7,7-dimethyl-2-oxo-bicyclo [2,2,1] hept-1-ylmethanesulfonic acid) and its salts; 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) propane-1,3-dione; alpha- (oxo-2-bomylidene-3) -toluene-4-sulfonic acid and its salts; 2-
  • composition according to the invention may also comprise at least one agent for artificial tanning and / or browning of the skin (self-tanning agents), for example dihydroxyacetone (DHA).
  • DHA dihydroxyacetone
  • composition according to the invention may comprise an artificial tanning agent and / or browning content of the skin ranging from 0.1 to 15% by weight, and especially ranging from 1 to 10% by weight, relative to the total weight. of the composition.
  • composition of the invention may be in the form of a skincare and / or makeup product for the skin and / or integuments. It can also be incorporated into a cabin care protocol.
  • the care of the day may be for example the product "AII Day AII Year” marketed by the company C.F.E.B. Sisley.
  • the present invention also relates to a process for the cosmetic treatment of at least one keratin material, in particular the skin and the integuments, comprising the application to said material of a cosmetic composition according to the invention.
  • This method may comprise the application of said composition at least once a day, for example in the evening.
  • This method may also comprise the application of said composition, at least once a day, in the two to ten days preceding exposure to the sun, in particular as part of a preventive action and / or preparation of the skin to sun exposure.
  • the subject of the present invention is also the use of a combination of 4 plant extracts according to the invention, said extracts being:
  • the present invention also relates to the use of a combination of 4 plant extracts according to the invention, said extracts being:
  • a plant extract of the species Physalis alkekengi L. or alkekenge for the preparation of a dermatological composition intended to prevent or treat aging of the skin and / or superficial body growths, in particular by a restorative action and / or protective.
  • FIG. 1 represents a histological section of skin explants without UVB irradiation and without formula A or B, observed under a microscope ( ⁇ 40) after Hematoxylin and Eosin staining.
  • FIG. 2 represents a histological section of skin explants subjected to UVB irradiations and without formula A or B, observed under a microscope ( ⁇ 40) after Hematoxylin and Eosin staining.
  • FIG. 3 represents a histological section of skin explants with UVB irradiations and with formula A, observed under a microscope ( ⁇ 40) after Hematoxylin and Eosin staining.
  • FIG. 4 represents a histological section of skin explants with UVB irradiations and with formula B, observed under a microscope ( ⁇ 40) after Hematoxylin and Eosin staining.
  • Example 1 Composition according to the invention
  • phase B Prepare phase B. When homogeneous, add it to phase A and stir gently.
  • phase C in the melter. - 5 min before emulsion, introduce the phase D in the phases A + B with stirring.
  • Formula A composition according to the invention: Complete formula with the combination of the four plant extracts
  • Study 1 Study "negative control” (skin explants without irradiation UVB and without formula A or B)
  • Study 3 Study of the effect of the cosmetic composition containing the combination of the four plant extracts (skin explants with UVB irradiation and with formula A)
  • Study 2 (See Figure 2): Skin showing signs of degeneration characteristic of UVB damage ("sun burn cells” and vacuoles)
  • Study 3 (See Figure 3): Skin with little sign of degeneration characteristic of UVB damage ("sun burn cells” and vacuoles)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to cosmetic and/or dermatological compositions including a combination of four plant extracts. The invention relates to a method for cosmetic and/or dermatological treatment of at least one keratin material, in particular skin, hair and nails, including applying a composition according to the invention to said material, as well as the use of the combination of four plant extracts as an anti-ageing agent, in particular as a repairing and/or protecting agent in a cosmetic and/or dermatological composition.

Description

COMPOSITION COSMETIQUE ET/OU DERMATOLOGIQUE A BASE COSMETIC AND / OR DERMATOLOGICAL COMPOSITION BASED
D'UNE COMBINAISON DE 4 EXTRAITS VEGETAUXA COMBINATION OF 4 VEGETABLE EXTRACTS
ET SES UTILISATIONSAND ITS USES
DESCRIPTIONDESCRIPTION
Domaine techniqueTechnical area
La présente invention concerne des compositions cosmétiques et/ou dermatologiques comprenant une combinaison de quatre extraits végétaux. L'invention concerne un procédé de traitement cosmétique et/ou dematologique d'au moins une matière kératinique, notamment la peau et les phanères, comprenant l'application sur ladite matière d'une composition selon l'invention, ainsi que l'utilisation de la combinaison des quatre extraits végétaux en tant qu'agent contre le vieillissement notamment en tant qu'agent réparateur et/ou agent protecteur dans une composition cosmétique et/ou dermatologique.The present invention relates to cosmetic and / or dermatological compositions comprising a combination of four plant extracts. The invention relates to a process for the cosmetic and / or dematological treatment of at least one keratin material, in particular the skin and the integuments, comprising the application to said material of a composition according to the invention, as well as the use of the combination of the four plant extracts as an anti-aging agent, especially as a repairing agent and / or protective agent in a cosmetic and / or dermatological composition.
Dans la description ci-dessous, les références entre crochets [ ] renvoient à la liste des références présentée à la fin du texte.In the description below, references in brackets [] refer to the list of references at the end of the text.
Etat de la techniqueState of the art
Le vieillissement de la peau et des phanères provoque notamment des modifications de la structure et/ou des fonctions cutanées.The aging of the skin and superficial body growths in particular causes changes in the structure and / or cutaneous functions.
Les principaux signes cliniques du vieillissement sont notamment l'apparition de ridules et rides profondes, la perte de fermeté et d'éclat du teint, et la diminution de l'hydratation de l'épiderme.The main clinical signs of aging include the appearance of fine lines and deep wrinkles, the loss of firmness and radiance of the complexion, and the decrease in the hydration of the epidermis.
Parmi les facteurs susceptibles d'être responsables de ce vieillissement, les radicaux libres sont principalement cités. Ceux-ci proviennent en partie de l'oxygène moléculaire et peuvent notamment être induits par les polluants atmosphériques et/ou le rayonnement ultraviolet. De nombreuses compositions ont déjà été mises au point afin de combattre activement les radicaux libres et les réactions d'oxydation qu'ils engendrent. On peut citer par exemple les compositions à base de vitamines A, C ou E, celles à base des polyphénols (notamment d'origine végétale), ou encore les compositions à base de quinoléine et ses dérivés. Des compositions à base d'acides aminés ont aussi été utilisées pour leur action antioxydante. Ces acides aminés présentent l'inconvénient d'être très rapidement métabolisés dans les cellules et possèdent ainsi une très faible efficacité. A ce jour, les compositions connues ne permettent pas de résoudre les problèmes du vieillissement dus à une réparation et/ou une protection insuffisante(s). De nombreux progrès restent encore à faire afin de pouvoir disposer d'actifs présentant des propriétés de réparation et/ou de protection satisfaisantes voire optimales. II subiste donc toujours un besoin pour une composition cosmétique et/ou dermatologique permettant de lutter efficacement contre le viellissement de la peau et des phanères notamment par une action réparatrice et/ou protectrice contre des agressions.Among the factors likely to be responsible for this aging, free radicals are mainly mentioned. These arise in part from molecular oxygen and may be induced by atmospheric pollutants and / or ultraviolet radiation. Many compositions have already been developed in order to actively combat free radicals and the oxidation reactions they generate. There may be mentioned, for example, compositions based on vitamins A, C or E, those based on polyphenols (in particular of plant origin), or even compositions based on quinoline and its derivatives. Amino acid compositions have also been used for their antioxidant action. These amino acids have the disadvantage of being very rapidly metabolized in cells and thus have a very low efficiency. To date, the known compositions do not solve the problems of aging due to inadequate repair and / or protection (s). Much progress is still to be made in order to have assets with satisfactory and even optimal repair and / or protection properties. There is therefore still a need for a cosmetic and / or dermatological composition that effectively combats the aging of the skin and the integuments, in particular by a restorative and / or protective action against aggressions.
Description de l'inventionDescription of the invention
La présente invention a précisément pour but de répondre à ce besoin en fournissant une composition cosmétique et/ou dermatologique comprenant une combinaison de 4 extraits végétaux, lesdits extraits étant : (a) un extrait végétal de l'espèce Oryza sativa L. ou riz, (b) un extrait végétal de l'espèce Triticum monococcum L. ou petit épeautre,The present invention is specifically intended to meet this need by providing a cosmetic and / or dermatological composition comprising a combination of 4 plant extracts, said extracts being: (a) a plant extract of the species Oryza sativa L. or rice, (b) a plant extract of the species Triticum monococcum L. or small spelled,
(c) un extrait végétal de l'espèce Salix alba L ou saule blanc, et(c) a plant extract of the species Salix alba L or white willow, and
(d) un extrait végétal de l'espèce Physalis alkekengi L ou alkékenge.(d) a plant extract of the species Physalis alkekengi L or alkekenge.
L'extrait végétal (a) peut être avantageusement obtenu à partir des grains de riz. L'extrait végétal (b) peut être avantageusement obtenu à partir des graines de petit épeautre.The plant extract (a) can be advantageously obtained from the rice grains. The plant extract (b) can be advantageously obtained from the seeds of small spelled.
L'extrait végétal (c) est avantageusement obtenu à partir des feuilles de saule blanc. L'extrait végétal (d) est avantageusement obtenu à partir de calices de physalis.The plant extract (c) is advantageously obtained from white willow leaves. The plant extract (d) is advantageously obtained from calyxes of physalis.
Selon un mode de réalisation particulier de l'invention, la composition cosmétique et/ou dermatologique comprend une combinaison de 4 extraits végétaux, lesdits extraits étant : (a) un extrait végétal de l'espèce Oryza sativa L. ou riz obtenu à partir des grains de riz,According to a particular embodiment of the invention, the cosmetic and / or dermatological composition comprises a combination of 4 plant extracts, said extracts being: (a) a plant extract of the species Oryza sativa L. or rice obtained from grains of rice,
(b) un extrait végétal de l'espèce Triticum monococcum L. ou petit épeautre obtenu à partir des graines de petit épeautre,(b) a plant extract of the species Triticum monococcum L. or small spelled obtained from the seeds of small spelled,
(c) un extrait végétal de l'espèce Salix alba L ou saule blanc obtenu à partir des feuilles de saule blanc, et(c) a plant extract of the species Salix alba L or white willow obtained from white willow leaves, and
(d) un extrait végétal de l'espèce Physalis alkekengi L ou alkékenge obtenu à partir de calices de physalis.(d) a plant extract of the species Physalis alkekengi L or alkekenge obtained from calyxes of physalis.
La combinaison des 4 extraits végétaux selon l'invention ainsi que la composition la comprenant, permettra de lutter contre le vieillissement de la peau et des phanères, en particulier par une action réparatrice et/ou protectrice.The combination of the 4 plant extracts according to the invention as well as the composition comprising it, will make it possible to combat aging of the skin and integuments, in particular by a restorative and / or protective action.
Dans le cadre de l'invention, le terme « peau » signifie l'organe qui enveloppe le corps et qui est constitué de plusieurs couches de tissus : - l'épiderme (couche superficielle),In the context of the invention, the term "skin" means the body which surrounds the body and which consists of several layers of tissue: - the epidermis (superficial layer),
- le derme (couche intermédiaire), etthe dermis (intermediate layer), and
- l'hypoderme (couche profonde).- the hypodermis (deep layer).
Ainsi, le terme peau s'applique en particulier au visage, aux lèvres, au contour des yeux, au cou, au corps et/ou au cuir chevelu. Le terme « phanères » selon l'invention englobe l'ensemble des productions épidermiques protectrices présentes à la surface du corps en particulier les poils, les cils, les sourcils, les ongles et/ou les cheveux.Thus, the term skin applies in particular to the face, the lips, the eye contour, the neck, the body and / or the scalp. The term "appendages" according to the invention encompasses all protective epidermal productions present on the surface of the body, in particular the hairs, eyelashes, eyebrows, nails and / or hair.
Dans un mode de réalisation particulier de l'invention, la combinaison des 4 extraits végétaux selon l'invention ainsi que la composition la comprenant permettra de lutter contre le viellissement de la peau par une action réparatrice et/ou protectrice en particulier le vieillissement du visage, des lèvres, du contour des yeux, du cou, du corps et/ou du cuir chevelu. Par « vieillissement » de la peau on entend notamment toute modification de l'aspect extérieur de la peau comme, par exemple, l'apparition de ridules et rides profondes, la perte de fermeté et d'éclat du teint et la diminution de l'hydratation de l'épiderme.In a particular embodiment of the invention, the combination of the 4 plant extracts according to the invention as well as the composition comprising it will make it possible to combat the aging of the skin by a repairing and / or protective action, in particular the aging of the face. , lips, eye area, neck, body and / or scalp. By "aging" of the skin is meant in particular any modification of the external appearance of the skin, such as, for example, the appearance of fine lines and deep wrinkles, the loss of firmness and radiance of the complexion and the decrease in the skin's appearance. hydration of the epidermis.
Selon un aspect de l'invention, la combinaison de 4 extraits végétaux ainsi qu'une composition la comprenant présentent une action réparatrice des matières kératiniques et, en outre, une action protectrice contre les agressions extérieures. L'utilisation de cette combinaison ou d'une composition la contenant, va permettre aux matières kératiniques d'être mieux réparés et mieux protégés des stress que produit l'environnement.According to one aspect of the invention, the combination of 4 plant extracts and a composition comprising it have a restorative action keratin materials and, in addition, a protective action against external aggression. The use of this combination or a composition containing it, will allow keratin materials to be better repaired and better protected from stress that the environment produces.
On entend par le terme « agressions extérieures », les agressions que peut produire l'environnement. A titre d'exemple, on peut citer des agressions telles que la pollution et les rayonnements UV.The term "external aggression" refers to the aggressions that the environment can produce. By way of example, mention may be made of aggressions such as pollution and UV radiation.
Les extraits végétaux de l'invention peuvent être obtenus par tout procédé d'extraction connu de l'homme du métier habituellement utilisé dans ce domaine et adapté aux extraits végétaux de l'invention. Parmi ces procédés on peut citer, par exemple, les procédés d'extraction par un solvant choisi dans le groupe comprenant l'eau, au moins un alcool, au moins un solvant organique, ou leur mélange ; le procédé d'extraction par entraînement à la vapeur ou hydro-distillation ; le procédé d'extraction par procédé mécanique ou par le CO2 supercritique, ou par distillation moléculaire.The plant extracts of the invention can be obtained by any extraction method known to those skilled in the art usually used in this field and adapted to the plant extracts of the invention. These methods include, for example, extraction processes with a solvent selected from the group consisting of water, at least one alcohol, at least one organic solvent, or their mixture; the process of extraction by steam distillation or hydro-distillation; the extraction process by mechanical process or by supercritical CO 2 , or by molecular distillation.
Les extraits selon l'invention sont avantageusement des extraits aqueux ou hydroglycoliques. Par exemple, l'extrait de calices de physalis peut être obtenu par solubilisation des calices de physalis, notamment réduits en poudre, dans un solvant, notamment choisi parmi l'eau, les alcools comprenant de 1 à 10 atomes de carbone, et plus particulièrement l'éthanol, ainsi qu'un mélange de ces solvants. Tout particulièrement, les calices de physalis sont solubilisés dans de l'eau.The extracts according to the invention are advantageously aqueous or hydroglycolic extracts. For example, the extract of calyxes of physalis can be obtained by solubilization of the calyxes of physalis, in particular reduced to powder, in a solvent, in particular chosen from water, alcohols comprising from 1 to 10 carbon atoms, and more particularly ethanol, as well as a mixture of these solvents. In particular, the chalices of physalis are solubilized in water.
La solution de calices de physalis peut être traitée enzymatiquement, notamment par au moins une protéase, notamment à une température allant de 15 à 45°C. La protéase peut être par exemple une endo- et/ou une exo-peptidase d'origine végétale (papaïne, bromélaïne).The solution of calyxes of physalis can be treated enzymatically, in particular by at least one protease, in particular at a temperature ranging from 15 to 45 ° C. The protease may be for example an endo- and / or exo-peptidase of plant origin (papain, bromelain).
Les phases solubles et insolubles peuvent être séparées, par exemple par filtration, décantation ou centrifugation ou une combinaison de ces moyens.The soluble and insoluble phases can be separated, for example by filtration, decantation or centrifugation or a combination of these means.
Tout particulièrement, la dispersion ou solution de calices de physalis peut subir un traitement thermique, en particulier destiné à inactiver les enzymes utilisées. L'homme du métier saura adapter le traitement thermique à l'enzyme utilisée. À la suite de ce traitement thermique on peut procéder à une filtration, par exemple en vue de séparer les enzymes in activées. La solution peut être concentrée, notamment par évaporation. La solution^ou_Je_solideterésultant__peu_Uêtre^stérilisé.--Dans le. cas d'une solution, la stérilisation peut être effectuée par une filtration stérilisante, par exemple par passage sur membrane microporeuse.In particular, the dispersion or solution of calyxes of physalis may undergo a heat treatment, in particular intended to inactivate the enzymes used. Those skilled in the art will know how to adapt the heat treatment to the enzyme used. As a result of this heat treatment it is possible to carry out a filtration, for example in order to separate the inactive enzymes. The solution can be concentrated, in particular by evaporation. The solution you ou_Je_solide ^ ^ résultant__peu_Uêtre sterilized .-- In. In the case of a solution, the sterilization can be carried out by sterilizing filtration, for example by passage over a microporous membrane.
En particulier, l'extrait de calices de physalis est un extrait aqueux. Tout particulièrement, 1 partie en poids de calices de physalis sec donnent de 1,5 à 3 parties en poids, et notamment de 2 à 2,5 parties en poids d'extrait de calices de physalis.In particular, the calyx extract of physalis is an aqueous extract. In particular, 1 part by weight of chalices of dry physalis give from 1.5 to 3 parts by weight, and in particular from 2 to 2.5 parts by weight of calyx extract of Physalis.
L'extrait de calices de physalis peut comprendre une teneur en matière sèche allant de 30 à 100 g/l, notamment de 40 à 80 g/l, et en particulier de 45 à 65 g/l.The calyx extract of physalis can comprise a solids content ranging from 30 to 100 g / l, in particular from 40 to 80 g / l, and in particular from 45 to 65 g / l.
L'extrait de calice de physalis peut comprendre des composés phénoliques. Ces composés phénoliques présents dans l'extrait de calices de physalis peuvent comprendre : - des composés hydroxycinnamiques, notamment dans une teneur allant de 60 à 99 % en poids, en particulier de 80 à 98 % en poids, voire de 90 à 96 % en poids par rapport au poids total de polyphénols, et des flavones notamment dans une teneur allant de 0,1 à 20 % en poids, en particulier de 1 à 10 % en poids, voire de 2,5 à 7 % en poids par rapport au poids total de polyphénols.The calyx extract of physalis can include phenolic compounds. These phenolic compounds present in the physalis calyx extract may comprise: hydroxycinnamic compounds, especially in a content ranging from 60 to 99% by weight, in particular from 80 to 98% by weight, or even from 90 to 96% by weight; weight relative to the total weight of polyphenols, and flavones especially in a content ranging from 0.1 to 20% by weight, in particular from 1 to 10% by weight, or even 2.5 to 7% by weight relative to total weight of polyphenols.
Les composés hydroxycinnamiques présents dans l'extrait de calices de physalis peuvent comprendre de l'acide férulique, notamment dans une teneur allant de 25 à 75 % en poids, en particulier de 30 à 70 % en poids, voire de 40 à 60 % en poids par rapport au poids total de composés hydroxycinnamiques.The hydroxycinnamic compounds present in the physalis calyx extract may comprise ferulic acid, especially in a content ranging from 25 to 75% by weight, in particular from 30 to 70% by weight, or even from 40 to 60% by weight. weight relative to the total weight of hydroxycinnamic compounds.
L'extrait de calices de physalis peut comprendre une teneur en polyphénols, exprimée en acide gallique, allant de 0,1 à 5 g/l, notamment de 0,25 à 2,5 g/l, et en particulier de 0,5 à 1 ,2 g/l.The calyx extract of physalis can comprise a polyphenol content, expressed in gallic acid, ranging from 0.1 to 5 g / l, in particular from 0.25 to 2.5 g / l, and in particular from 0.5 at 1, 2 g / l.
Parmi les extraits de calices de physalis utilisables selon l'invention, on peut tout particulièrement citer ceux commercialisés par la société Sjlak,_notammej3t_s_ous_4a,dén^^^ physalis ».Among the extracts of calyxes of physalis that may be used according to the invention, mention may be made especially of those sold by the company Sjlak, which is in accordance with the invention and denotes physalis.
La composition selon l'invention peut comprendre une teneur en extrait de Physalis alkekengi L. ou alkékenge, allant de 0,1 à 20 % en poids, notamment de 0,2 à 10 % en poids, et en particulier de 0,3 à 5 % en poids, par rapport au poids total de la composition. Les autres extraits végétaux de la combinaison de l'invention peuvent être obtenus par un procédé tel que décrit dans [1] et [2], ou encore, par exemple, par extraction au moyen d'un solvant choisi parmi l'eau, un alcool, un glycol, la glycérine, l'acétone ou un mélange de ces solvants. Par exemple, il peut s'agir d'un extrait aqueux ou hydroglycolique. Après macération des graines, de la poudre ou des feuilles de la plante concernée dans un mélange d'eau et, par exemple, de butylène glycol, de propylène glycol ou de pentylène glycol, l'extrait est filtré.The composition according to the invention may comprise an extract content of Physalis alkekengi L. or alkenkene, ranging from 0.1 to 20% by weight, in particular from 0.2 to 10% by weight, and in particular from 0.3 to 5% by weight, relative to the total weight of the composition. The other plant extracts of the combination of the invention can be obtained by a process as described in [1] and [2], or else, for example, by extraction using a solvent chosen from water, alcohol, a glycol, glycerin, acetone or a mixture of these solvents. For example, it may be an aqueous or a glycolic extract. After maceration of seeds, powder or leaves of the plant concerned in a mixture of water and, for example, butylene glycol, propylene glycol or pentylene glycol, the extract is filtered.
Dans le cas d'un extrait û'Oryza sativa L. ou riz, notamment un extrait de grains û'Oryza sativa L. ou riz, un liquide limpide jaune d'odeur caractéristique présentant les caractéristiques analytiques suivantes est obtenu :In the case of an extract of Oryza sativa L. or rice, in particular an extract of Oryza sativa L. or rice grains, a clear yellow liquid of characteristic odor having the following analytical characteristics is obtained:
- pH (25°C) : 5,0 à 6,0- pH (25 ° C): 5.0 to 6.0
- indice de réfraction (200C) : 1 ,360 à 1,390 - extrait sec (1050C) : 0,30 à 0,50 % m/mrefractive index (20 ° C.): 1. 360 to 1.390 dry extract (105 ° C.): 0.30 to 0.50% w / w
Un extrait d'Oryza sativa L. ou riz, utilisable selon l'invention, peut également être obtenu auprès de la société ISP - VINCIENCE, commercialisé sous la dénomination commerciale ORSIRTINE ®.An extract of Oryza sativa L. or rice, usable according to the invention, can also be obtained from the company ISP-VINCIENCE, marketed under the trade name ORSIRTINE®.
La composition selon l'invention peut comprendre une teneur en extrait de d'Oryza sativa L ou riz, allant de 0,1 à 20 % en poids, notamment de 0,2 à 10 % en poids, et en particulier de 0,5 à 5 % en poids, par rapport au poids total de la composition.The composition according to the invention may comprise an extract content of Oryza sativa L or rice, ranging from 0.1% to 20% by weight, in particular from 0.2% to 10% by weight, and in particular from 0.5% by weight. at 5% by weight, relative to the total weight of the composition.
Dans le cas d'un extrait de Triticum monococcum L. ou petit épeautre, notamment un extrait de graines de Triticum monococcum L. ou petit épeautre, un liquide limpide jaune clair d'odeur caractéristique présentant les caractéristiques_analytiques-suivantes-est-θbtenu -:In the case of an extract of Triticum monococcum L. or small spelled, in particular a seed extract of Triticum monococcum L. or small spelled, a clear yellow liquid of characteristic odor having the following analytical characteristics is obtained:
- pH (25°C) : 5,0 à 6,0- pH (25 ° C): 5.0 to 6.0
- indice de réfraction (200C) : 1 ,365 à 1 ,375refractive index (20 ° C.): 1.365 to 1.375
- extrait sec (105X) : 0,40 à 0,80 % m/m Un extrait de Triticum monococcum L ou petit épeautre, utilisable selon l'invention peut également être obtenu auprès de la société ISP - VINCIENCE sous la dénomination commerciale PHYTOQUINTESCINE® - dry extract (105X): 0.40 to 0.80% m / m An extract of Triticum monococcum L or small spelled, usable according to the invention can also be obtained from the company ISP - VINCIENCE under the trade name PHYTOQUINTESCINE ®
La composition selon l'invention peut comprendre une teneur en extrait de Triticum monococcum L. ou petit épeautre allant de 0,1 à 20 % en poids, notamment de 0,2 à 10 % en poids, et en particulier de 0,5 à 5 % en poids, par rapport au poids total de la composition.The composition according to the invention may comprise an extract content of Triticum monococcum L. or small spelled ranging from 0.1 to 20% by weight, especially from 0.2 to 10% by weight, and in particular from 0.5 to 5% by weight, relative to the total weight of the composition.
Dans le cas d'un extrait de Salix alba L ou saule blanc, notamment un extrait de feuilles de Salix alba L. ou saule blanc, on obtient un liquide marron d'odeur caractéristique présentant les caractéristiques analytiques suivantes :In the case of an extract of Salix alba L or white willow, especially an extract of leaves of Salix alba L. or white willow, we obtain a brown liquid of characteristic odor having the following analytical characteristics:
- pH (25°C) : 4,5 à 6,0- pH (25 ° C): 4.5 to 6.0
- indice de réfraction (200C) : 1 ,348 à 1 ,354refractive index (20 ° C.): 1.348 to 1.354
- extrait sec (1050C) : 4,00 à 6,50 % m/m - Teneur en eau : 88,50 à 91 ,50 % m/m- dry extract (105 0 C): 4.00 to 6.50% m / m - Water content: 88.50 to 91, 50% m / m
Un extrait de Salix alba L. ou saule blanc utilisable selon l'invention peut également être obtenu auprès de la société SILAB sous la dénomination commerciale ASTRESSYL® GR .An extract of Salix alba L. White willow or used according to the invention may also be obtained from the company Silab under the trade name ASTRESSYL ® GR.
La composition selon l'invention peut comprendre une teneur en extrait de Salix alba L. ou saule blanc allant allant de 0,1 à 20 % en poids, notamment de 0,2 à 10 % en poids, et en particulier de 0,5 à 5 % en poids, par rapport au poids total de la composition.The composition according to the invention may comprise an extract content of Salix alba L. or white willow ranging from 0.1 to 20% by weight, especially from 0.2 to 10% by weight, and in particular from 0.5 at 5% by weight, relative to the total weight of the composition.
Les méthodes et appareillages utilisés pour déterminer les caractéristiques analytiques desdits extraits, peuvent ainsi être décrits : - Mesure du pH à 25°CThe methods and apparatus used to determine the analytical characteristics of said extracts can thus be described: - Measurement of the pH at 25 ° C.
-Pχincipjej-_Le_p.H-^sUa_mesuie^quLreprésente conventionnellement la concentration en ions hydrogène d'une solution aqueuse.-Pχincipjej-_Le_p.H- ^ ^ sUa_mesuie quLreprésente conventionally the hydrogen ion concentration of an aqueous solution.
Matériel spécifique : pH-mètre Seven-Multi Mettler Toledo muni d'une électrode combinée de pénétration du type InLab 427 ou équivalent. Méthode : Plonger l'électrode de mesure dans la substance à examiner àSpecific equipment: Seven-Multi Mettler Toledo pH meter with a combination penetration electrode of the InLab 427 type or equivalent. Method: Immerse the measuring electrode in the test substance at
25°C. Lorsque la valeur de pH est stable, noter cette valeur. - Mesure de l'indice de réfraction à 2O0C25 ° C. When the pH value is stable, record this value. - Measurement of the refractive index at 20 ° C.
Principe : L'indice de réfraction d'un milieu rapporté à l'air est égal au rapport du sinus de l'angle d'incidence d'un rayon lumineux dans l'air, au sinus de l'angle de réfraction du rayon réfracté dans le milieu considéré. Dans cette méthode, l'indice de réfraction est déterminé à 200C ± 1°C et rapporté à la raie D du sodium.Principle: The refractive index of an airborne medium is equal to the ratio of the sinus of the angle of incidence of a light ray in the air to the sine of the refracted angle of refraction. in the medium in question. In this method, the refractive index is determined at 20 ° C. ± 1 ° C. and is based on the sodium D line.
Matériel spécifique : Réfractomètre d'Abbe avec cristal thermostaté à 200C ± 1°C. Méthode : Déposer une goutte de l'échantillon à examiner à 200C ± 1°C sur le prisme du réfractomètre. Effectuer le réglage du réfractomètre et lire la valeur mesurée.Specific material: Abbe refractometer with crystal thermostatic at 20 0 C ± 1 ° C. Method: Deposit a drop of the sample to be examined at 20 0 ± 1 ° C on the prism of the refractometer. Adjust the refractometer and read the measured value.
- Détermination du pourcentage d'extrait sec Principe : L'extrait sec représente le pourcentage de l'ensemble des substances qui ne se volatilisent pas par rapport aux substances de la prise d'essai d'un échantillon. La substance à examiner est placée à l'étuve à 105°C ± 2°C pendant 12h ± 2h. Matériel spécifique : Etuve à 1050C ± 2°C de type Memmert ou équivalent. Méthode : Prendre un flacon à tare, retirer toute trace d'eau en le mettant au moins 1 heure à l'étuve à 1050C puis au dessicateur le temps du refroidissement. Faire la tare du flacon. Introduire environ, exactement 1g du substance à examiner. Mettre à l'étuve à 1050C ± 2°C. Après 12 heures (plus ou moins 2 heures) sortir le flacon et laisser refroidir au dessicateur. Peser le flacon et calculer la masse de la substance examinée.- Determination of the percentage of dry extract Principle: The dry extract represents the percentage of all the substances which do not volatilize with respect to the substances of the test portion of a sample. The substance to be examined is placed in an oven at 105 ° C ± 2 ° C for 12h ± 2h. Specific equipment: oven at 105 0 ± 2 ° C Memmert type or equivalent. Method: Take a tare flask, remove all traces of water by putting it at least 1 hour in an oven at 105 0 C and then in the desiccator the time of cooling. Make the bottle tare. Introduce approximately exactly 1g of the substance to be examined. Put in the oven at 105 0 ± 2 ° C. After 12 hours (more or less 2 hours) remove the bottle and cool in the desiccator. Weigh the vial and calculate the mass of the substance being examined.
- Mesure de la teneur en eau par la méthode de Karl Fisher Principe : Le réactif Hydranal est une solution d'iode (I2) et d'anhydride sulfureux (SO2) dans du méthanol (CH3OH). En l'absence d'eau le réactif est stable, mais en présence d'eau, l'anhydride sulfureux est oxydé en trioxyde ou en acide sulfurique par l'iode suivant la réaction : I2 + SO2 + 2H2O -> 2Hl + H2SO4 - Measurement of water content by the Karl Fisher method Principle: The Hydranal reagent is a solution of iodine (I 2 ) and sulfur dioxide (SO 2 ) in methanol (CH 3 OH). In the absence of water the reagent is stable, but in the presence of water, the sulfur dioxide is oxidized to trioxide or sulfuric acid by the iodine following the reaction: I 2 + SO 2 + 2H 2 O -> 2Hl + H 2 SO 4
L'iode et le dioxide de soufre réagissent l'un sur l'autre en présence d'eau. Tant que la solution contient de l'eau, la polarisation de la cathode s'oppose au passage du courant ; la goutte de réactif titrant en excès apporte de l'iode libre qui provoque la dépolarisation de la cathode et permet le passage d'un courant décelé par un dispositif électrique approprié.Iodine and sulfur dioxide react with each other in the presence of water. As long as the solution contains water, the polarization of the cathode is opposed to the passage of the current; the drop of reagent titrant in excess brings free iodine which causes depolarization of the cathode and allows the passage of a current detected by a suitable electrical device.
Appareil spécifique : Titrimètre automatique Karl Fisher 701 KF ou équivalent. Méthode : 1mL de réactif titrant correspond à environ 5 mg d'eau. Mettre dans l'appareil une prise d'essai du produit à analyser de façon à consommer environ 4 mL de réactif titrant. Vérifier l'étanchéité du système et lancer le dosage.Specific device: Karl Fisher 701 KF Automatic Titrimeter or equivalent. Method: 1 ml of titrant corresponds to approximately 5 mg of water. Put in the device a test portion of the product to be analyzed so as to consume about 4 mL of titrant reagent. Check the tightness of the system and start the dosing.
La composition selon l'invention peut se présenter sous toute forme connue de l'homme du métier dans le domaine de la cosmétique et/ou dermatologique pour l'application sur la peau en particulier le visage, les lèvres, le contour des yeux, le cou, le corps et/ou le cuir chevelu et/ou les phanères en particulier les poils, les cils, les sourcils, les ongles et/ou les cheveux. Ainsi, la composition selon l'invention, peut être sous forme : d'une solution ou suspension aqueuse, alcoolique ou huileuse de type lotion ou sérum, d'une émulsion de consistance liquide ou semi liquide de type lait, obtenue par dispersion d'une phase grasse dans une phase aqueuse (émulsion Huile dans Eau : H/E) ou inversement (Eau dans Huile : EJH), d'une émulsion de type crème H/E ou E/H, d'un gel, ou d'un gel-émulsion, d'un masque, - d'un produit anhydre comme par exemple une huile, un baume, une poudre. Les compositions de l'invention peuvent encore être sous la forme d'une mousse ou sous une forme adaptée pour aérosol comprenant également un agent propulseur sous pression.The composition according to the invention may be in any form known to those skilled in the field of cosmetics and / or dermatology for application to the skin, in particular the face, the lips, the eye contour, the neck, body and / or scalp and / or integuments, in particular hairs, eyelashes, eyebrows, nails and / or hair. Thus, the composition according to the invention may be in the form of: an aqueous or alcoholic solution or suspension of the lotion or serum type, an emulsion of liquid or semi-liquid consistency of milk type, obtained by dispersion of a fatty phase in an aqueous phase (oil in water emulsion: O / W) or conversely (water in oil: EJH), an O / W or W / O cream emulsion, a gel, or a gel-emulsion, a mask, - an anhydrous product such as an oil, a balm, a powder. The compositions of the invention may also be in the form of a foam or in a form suitable for aerosol also comprising a propellant under pressure.
Selon un mode de réalisation particulier, la composition selon l'invention est une composition pour la peau, en particulier pour le soin de la peau, en particulier le visage, les lèvres, le contour des yeux, le cou, le corps et/ou le cuir chevelu.According to a particular embodiment, the composition according to the invention is a composition for the skin, in particular for the care of the skin, in particular the face, the lips, the eye contour, the neck, the body and / or scalp.
La composition peut alors être par exemple une émulsion H/E ou E/H, de type lait ou de type crème. La composition selon l'invention, lorsqu'elle est sous forme d'émulsion H/E, comprend une phase aqueuse qui forme la phase continue de la composition.The composition may then be, for example, an O / W or W / O emulsion, of the milk or cream type. The composition according to the invention, when it is in the form of an O / W emulsion, comprises an aqueous phase which forms the continuous phase of the composition.
La phase aqueuse peut alors comprendre essentiellement voire exclusivement de l'eau. Elle peut également comprendre un mélange d'eau et de solvants organiques miscibles à l'eau (miscibilité dans l'eau supérieure à 50 % en poids à 25 0C) comme les alcools ayant de 2 à 5 atomes de carbone choisis dans le groupe comprenant l'éthanol, l'isopropanol, le tert-butanol et le n-butanol, et les alkylèneglycols ayant de 2 à 8 atomes de carbone choisis dans le groupe comprenant le propylène glycol et ses dérivés, 1 ,3- butylène glycol, le pentylène glycol, le dipropylène glycol, les cétones ayant 3 à 4 atomes de carbone et les polyols choisis dans le groupe comprenant la glycérine.The aqueous phase can then essentially or exclusively include water. It may also comprise a mixture of water and organic solvents miscible with water (miscibility in water greater than 50% by weight at 25 0 C) such as alcohols having 2 to 5 carbon atoms chosen from the group comprising ethanol, isopropanol, tert-butanol and n-butanol, and alkylene glycols having 2 to 8 carbon atoms selected from the group consisting of propylene glycol and its derivatives, 1,3-butylene glycol, pentylene glycol, dipropylene glycol, ketones having 3 to 4 carbon atoms and polyols selected from the group consisting of glycerine.
La phase aqueuse (eau et éventuellement les solvants organiques miscibles à l'eau) peut être présente à une teneur allant de 1 à 95 % en poids, notamment allant de 10 à 90 % en poids, et en particulier allant de 60 à 85 % en poids, par rapport au poids total de la composition.The aqueous phase (water and optionally water-miscible organic solvents) may be present in a content ranging from 1 to 95% by weight, in particular ranging from 10 to 90% by weight, and in particular ranging from 60 to 85% by weight. by weight, relative to the total weight of the composition.
La phase aqueuse peut, en outre, comprendre des agents gélifiants/stabilisants tels que les gommes, les polymères synthétiques et leurs dérivés. Pour former une émulsion H/E, une phase grasse ou huileuse est dispersée dans ladite phase aqueuse. Cette phase grasse ou huileuse est généralement présente en plus faible quantité, par exemple pouvant aller de 5 à 50% en poids, en particulier de 15 à 40 % en poids, par rapport au poids total de la composition. La phase grasse ou huileuse peut comprendre un corps gras liquide à température ambiante (200C) et à pression atmosphérique. Ce corps gras liquide peut être choisi parmi les huiles volatiles ou non. Elle peut comprendre, par exemple, au moins une huile de silicone telle que définie ultérieurement, au moins une huile hydrocarbonée volatile ou non telle que définie ultérieurement ou encore un mélange de ces huiles. La phase grasse ou huileuse peut également comprendre un corps gras solide à température ambiante (200C) et à pression atmosphérique telle que les cires, les corps gras pâteux, les gommes et leurs mélanges. La phase grasse peut en outre contenir des agents gélifiants/stabilisants et structurants d'huiles de nature organique et/ou des solvants organiques lipophiles.The aqueous phase may further comprise gelling agents / stabilizers such as gums, synthetic polymers and their derivatives. To form an O / W emulsion, a fatty or oily phase is dispersed in said aqueous phase. This fatty or oily phase is generally present in a smaller amount, for example ranging from 5 to 50% by weight, in particular from 15 to 40% by weight, relative to the total weight of the composition. The fatty or oily phase may comprise a fatty substance which is liquid at ambient temperature (20 ° C.) and at atmospheric pressure. This liquid fatty substance may be chosen from volatile oils or not. It may comprise, for example, at least one silicone oil as defined later, at least one volatile or non-volatile hydrocarbon oil as defined later, or a mixture of these oils. The oily or oily phase may also comprise a solid fatty substance at ambient temperature (20 ° C.) and at atmospheric pressure such as waxes, pasty fatty substances, gums and mixtures thereof. The fatty phase may also contain gelling agents / stabilizers and structuring oils of organic nature and / or lipophilic organic solvents.
La composition selon l'invention, lorsqu'elle est sous forme d'émulsion E/H comprend une phase grasse ou huileuse qui forme la phase continue de la composition. La phase grasse peut comprendre au moins un corps gras liquide à température ambiante (25°C) et à pression atmosphérique et/ou au moins un corps gras solide à température ambiante et à pression atmosphérique telle que les cires, les corps gras pâteux, les gommes et leurs mélanges. La phase grasse peut en outre contenir des agents gélifiants/stabilisants et structurants d'huiles de nature organique et/ou des solvants organiques lipophiles. La phase grasse peut notammenLcomprendre._à_titre--de-Cθrps-gras-liquide,-au-moins-une huile volatile ou non volatile ou leur mélange.The composition according to the invention, when in the W / O emulsion form, comprises a fatty or oily phase which forms the continuous phase of the composition. The fatty phase may comprise at least one fatty substance that is liquid at room temperature (25 ° C.) and at atmospheric pressure and / or at least one solid substance that is solid at ambient temperature and at atmospheric pressure, such as waxes, pasty fatty substances, gums and mixtures thereof. The fatty phase may also contain gelling agents / stabilizers and structuring oils of organic nature and / or lipophilic organic solvents. The fatty phase may include, but is not limited to, a fatty-liquid-to-liquid-at-the-least volatile or nonvolatile oil or mixture thereof.
Par « huile volatile », on entend au sens de l'invention toute huile susceptible de s'évaporer au contact de la peau en moins d'une heure, à température ambiante (200C) et pression atmosphérique. Les huiles volatiles de l'invention peuvent être des huiles cosmétiques volatiles, liquides à température ambiante, ayant une pression de vapeur non nulle, à température ambiante et pression atmosphérique, allant notamment de 0,01 à 300 mm de Hg (1 ,33 Pa à 40.000 Pa) et en particulier supérieure à 0,3 mm de Hg (40 Pa).For the purposes of the invention, the term "volatile oil" means any oil capable of evaporating on contact with the skin in less than one hour, at ambient temperature (20 ° C.) and atmospheric pressure. The oils The volatile compounds of the invention may be volatile cosmetic oils which are liquid at ambient temperature and have a non-zero vapor pressure at ambient temperature and atmospheric pressure, in particular ranging from 0.01 to 300 mmHg (1.33 Pa to 40,000). Pa) and in particular greater than 0.3 mm Hg (40 Pa).
Par "huile non volatile", on entend une huile restant sur la peau à température ambiante (200C) et pression atmosphérique au moins plusieurs heures et ayant notamment une pression de vapeur inférieure à 0,01 mm de Hg (1 ,33 Pa). Ces huiles volatiles ou non volatiles peuvent être des huiles hydrocarbonées notamment d'origine végétale, des huiles siliconées, ou leurs mélanges.By "non-volatile oil" is meant an oil remaining on the skin at ambient temperature (20 ° C.) and atmospheric pressure for at least several hours and having in particular a vapor pressure of less than 0.01 mmHg (1.33 Pa). ). These volatile or non-volatile oils may be hydrocarbon oils, in particular of plant origin, silicone oils, or mixtures thereof.
On entend par « huile hydrocarbonée », une huile contenant principalement des atomes d'hydrogène et de carbone et éventuellement des atomes d'oxygène, d'azote, de soufre et/ou de phosphore.The term "hydrocarbon-based oil" means an oil containing mainly hydrogen and carbon atoms and optionally oxygen, nitrogen, sulfur and / or phosphorus atoms.
Les huiles hydrocarbonées volatiles peuvent être choisies parmi les huiles hydrocarbonées ayant de 8 à 16 atomes de carbone, et notamment les alcanes ramifiés en C8-C16, comme les isoalcanes en C8-C16 d'origine pétrolière (appelées aussi isoparaffines), comme l'isododécane (encore appelé 2,2,4,4,6-pentaméthylheptane), l'isodécane, l'isohexadécane, et par exemple les huiles vendues sous les noms commerciaux d'Isopars® ou de Permetyls®, les esters ramifiés en C8-C16 tels que le néopentanoate d'iso-hexyle, et leurs mélanges.The volatile hydrocarbon oils may be chosen from hydrocarbon-based oils containing from 8 to 16 carbon atoms, and in particular C8-C16 branched alkanes, such as C8-C16 isoalkanes of petroleum origin (also called isoparaffins), such as isododecane (also known as 2,2,4,4,6-pentamethylheptane), isodecane, isohexadecane, and for example the oils sold under the trade names Isopar or Permethyl ® ®, branched esters, C8- C16 such as isohexyl neopentanoate, and mixtures thereof.
Comme huiles volatiles, on peut aussi utiliser les silicones volatiles, comme par exemple les huiles de silicones linéaires ou cycliques volatiles, notammentjcelles_ayan_Lunej/isc_osité-inférieure-ou-égale à 8 centistokes (8 x 10~6 m2/s), et ayant notamment de 2 à 7 atomes de silicium, ces silicones comportant éventuellement des groupes alkyle ou alkoxy ayant de 1 à 10 atomes de carbone. Comme huile de silicone volatile utilisable dans l'invention, on peut citer notamment l'octaméthyl cyclotétrasiloxane, le décaméthyl cyclopentasiloxane, le dodécaméthyl cyclohexasiloxane, l'heptaméthyl hexyltrisiloxane, l'heptaméthyloctyl trisiloxane, l'hexaméthyl disiloxane, l'octaméthyl trisiloxane, le décaméthyl tétrasiloxane, le dodécaméthyl pentasiloxane et leurs mélanges.Volatile silicones, such as, for example, volatile linear or cyclic silicone oils, especially those with less than or equal to 8 centistokes (8 × 10 -6 m 2 / s), are used as volatile oils. in particular from 2 to 7 silicon atoms, these silicones optionally comprising alkyl or alkoxy groups having from 1 to 10 carbon atoms. As volatile silicone oil that may be used in the invention, mention may be made in particular of octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane and dodecamethylcyclohexasiloxane. heptamethyl hexyltrisiloxane, heptamethyloctyltrisiloxane, hexamethyl disiloxane, octamethyltrisiloxane, decamethyltetrasiloxane, dodecamethylpentasiloxane and mixtures thereof.
Lorsque la composition selon l'invention comprend une huile volatile, cette dernière peut être présente à une teneur allant de 0,1 à 98 % en poids, notamment de 1 à 65 % en poids, et en particulier de 2 à 50 % en poids, par rapport au poids total de la composition.When the composition according to the invention comprises a volatile oil, the latter may be present in a content ranging from 0.1 to 98% by weight, in particular from 1 to 65% by weight, and in particular from 2 to 50% by weight. , relative to the total weight of the composition.
Les huiles non volatiles peuvent notamment être choisies parmi les huiles hydrocarbonées le cas échéant fluorées et/ou les huiles siliconées non volatiles.The non-volatile oils may in particular be chosen from fluorinated hydrocarbon oils which may be fluorinated and / or non-volatile silicone oils.
Comme huile hydrocarbonée non volatile, on peut notamment citer :As non-volatile hydrocarbon oil, mention may notably be made of:
- les huiles hydrocarbonées d'origine animale,- hydrocarbon oils of animal origin,
- les huiles hydrocarbonées d'origine végétale telles que le squalane,hydrocarbon oils of vegetable origin, such as squalane,
- les huiles hydrocarbonées d'origine végétale telles que les triglycérides constitués d'esters d'acides gras et de glycérol dont les acides gras peuvent avoir des longueurs de chaînes variées de C4 à C24, ces dernières pouvant être linéaires ou ramifiées, saturées ou insaturées; ces huiles sont notamment les huiles de germe de blé, de tournesol, de prune, de pépins de raisin, de sésame, de maïs, d'abricot, de ricin, d'avocat, d'olive, de soja, d'amande douce, de palme, de colza, de coton, de noisette, de macadamia, de sésame, de courge, de colza, de cassis, d'onagre, de carthame, de rosier muscat; le beurre de karité ; ou les triglycérides des acides caprylique/caprique comme ceux vendus par la société Stéarineries Dubois ; ou encore les triglycérides d'origine végétale hydrogénés comme par exemple les dérivés d'huile de ricin hydrogénée, rJes éthers de synthèse ayant de 10 à 40 atomes de carbone,hydrocarbon-based oils of plant origin, such as triglycerides consisting of esters of fatty acids and of glycerol, the fatty acids of which may have various chain lengths of C4 to C24, the latter may be linear or branched, saturated or unsaturated; ; these oils include wheat germ, sunflower, plum, grape seed, sesame, maize, apricot, castor, avocado, olive, soya, sweet almond oil palm, rapeseed, cotton, hazelnut, macadamia, sesame, pumpkin, rapeseed, blackcurrant, evening primrose, safflower, muscat rose; shea butter; or triglycerides of caprylic / capric acids such as those sold by the company Stéarineries Dubois; or alternatively hydrogenated triglycerides of vegetable origin, for example derivatives of hydrogenated castor oil, synthetic ethers having from 10 to 40 carbon atoms,
- les hydrocarbures linéaires ou ramifiés, d'origine minérale ou synthétique tels que la vaseline, les polydécènes, le polyisobutène hydrogéné tel que le Parleam, le squalane et leurs mélanges, - les esters de synthèse comme les huiles de formule R1COOR2 dans laquelle Ri représente le reste d'un acide gras linéaire ou ramifié comportant de 1 à 40 atomes de carbone et R2 représente une chaîne hydrocarbonée notamment ramifiée contenant de 1 à 40 atomes de carbone à condition que Ri + R2 soit supérieur ou égal à 10 atomes de carbone, comme par exemple l'huile de Purcellin (octanoate de céto stéaryle), le myristate d'isopropyle, le palmitate d'isopropyle, les benzoates d'alcools ayant de 2 à 5 atomes de carbone, le laurate d'hexyle, l'adipate de diisopropyle, l'isononanoate d'isononyle, le palmitate de 2-éthyl-hexyle, l'isostéarate d'isostéaryle, des heptanoates, octanoates, décanoates ou ricinoléates d'alcools ou de polyalcools comme le dioctanoate de propylène glycol; les esters hydroxylés comme le lactate d'isostéaryle, le malate de di-isostéaryle; les esters de polyols et les esters du pentaérithrytol,linear or branched hydrocarbons of mineral or synthetic origin, such as petroleum jelly, polydecenes, hydrogenated polyisobutene such as Parleam, squalane and their mixtures; synthetic esters, such as the oils of formula R 1 COOR 2 in which R 1 represents the remainder of a linear or branched fatty acid having 1 to 40 carbon atoms and R 2 represents a particularly branched hydrocarbon chain containing from 1 to 40 carbon atoms, provided that R 1 + R 2 is greater than or equal to 10 carbon atoms, for example Purcellin oil. (keto stearyl octanoate), isopropyl myristate, isopropyl palmitate, benzoates of alcohols having 2 to 5 carbon atoms, hexyl laurate, diisopropyl adipate, isononanoate isononyl, 2-ethylhexyl palmitate, isostearyl isostearate, heptanoates, octanoates, decanoates or ricinoleates of alcohols or polyalcohols such as propylene glycol dioctanoate; hydroxylated esters such as isostearyl lactate, diisostearyl malate; polyol esters and pentaerythritol esters,
- les alcools gras liquides à température ambiante à chaîne carbonée ramifiée et/ou insaturée ayant de 12 à 26 atomes de carbone comme l'octyl dodécanol, l'alcool isostéarylique, l'alcool oléique, le 2-hexyldécanol, le 2-butyloctanol, et le 2 undécylpentadécanol,at room temperature liquids with a branched and / or unsaturated carbon chain having from 12 to 26 carbon atoms, such as octyl dodecanol, isostearyl alcohol, oleic alcohol, 2-hexyldecanol or 2-butyloctanol, and 2 undecylpentadecanol,
- les acides gras supérieurs tels que l'acide oléique, l'acide linoléique, l'acide linolénique et leurs mélanges.higher fatty acids such as oleic acid, linoleic acid, linolenic acid and mixtures thereof.
Les huiles de silicone non volatiles utilisables dans la composition selon l'invention peuvent être les polydiméthylsiloxanes (PDMS) non volatiles, les polydiméthylsiloxanes comportant des groupements alkyle ou alcoxy pendants et/ou en bouts de chaîne siliconée, groupements ayant chacun de 2 à 24 atomes de carbone, les silicones phénylées comme les phényl triméthicones, les phényl diméthicones, les phényl triméthyloxy diphénylsiloxanes, les diphényl diméthicones, les diphényl méthyldiphényl trisiloxanes. et les 2- phényléthyLtriméthylsiloxysilicates.The non-volatile silicone oils that may be used in the composition according to the invention may be non-volatile polydimethylsiloxanes (PDMS), polydimethylsiloxanes comprising pendant alkyl or alkoxy groups and / or silicone chain ends, groups each having from 2 to 24 atoms. carbon, phenyl silicones such as phenyl trimethicones, phenyl dimethicones, phenyl trimethyloxy diphenylsiloxanes, diphenyl dimethicones, diphenyl methyldiphenyl trisiloxanes. and 2-phenylethyltrimethylsiloxysilicates.
Les huiles non volatiles peuvent être présentes dans la composition selon l'invention en une teneur allant de 0,01 à 90 % en poids, notamment de 0,1 % à 85 % en poids, et en particulier de 1 % à 70 % en poids, par rapport au poids total de la composition. Plus généralement, le corps gras liquide à température ambiante et à pression atmosphérique peut être présent à raison de 0,01 à 90 % en poids et notamment de 0,1 à 80 % en poids, par rapport au poids de la phase grasse. En ce qui concerne le corps gras solide à température ambianteThe non-volatile oils may be present in the composition according to the invention in a content ranging from 0.01 to 90% by weight, especially from 0.1% to 85% by weight, and in particular from 1% to 70% by weight. weight, relative to the total weight of the composition. More generally, the fatty substance which is liquid at ambient temperature and at atmospheric pressure may be present in a proportion of from 0.01 to 90% by weight and in particular from 0.1 to 80% by weight, relative to the weight of the fatty phase. Regarding solid fat at room temperature
(200C) et à pression atmosphérique, il peut être choisi parmi les cires, les corps gras pâteux, les gommes et leurs mélanges. Ce corps gras solide peut être présent à raison de 0,01 à 50 % en poids, notamment de 0,1 à 40 % en poids et en particulier de 0,2 à 30 % en poids, par rapport au poids total de la composition.(20 0 C) and at atmospheric pressure, it can be chosen from waxes, pasty fatty substances, gums and mixtures thereof. This solid fatty substance may be present in a proportion of from 0.01% to 50% by weight, in particular from 0.1% to 40% by weight and in particular from 0.2% to 30% by weight, relative to the total weight of the composition. .
Ainsi, la composition selon l'invention peut comprendre au moins un composé gras pâteux à température ambiante (environ 200C).Thus, the composition according to the invention may comprise at least one pasty fatty compound at ambient temperature (approximately 20 ° C.).
Par « corps gras pâteux » au sens de l'invention, on entend des corps gras capables de fondre au contact de la peau, par exemple des corps ayant un point de fusion allant de 25 à 45°C.For the purposes of the invention, the term "pasty fatty substance" means fatty substances capable of melting in contact with the skin, for example bodies having a melting point ranging from 25 ° to 45 ° C.
Plus particulièrement, ces corps gras peuvent être des composés hydrocarbonés, éventuellement de type polymérique ; ils peuvent également être choisis parmi les composés siliconés; ils peuvent aussi se présenter sous forme d'un mélange de composés hydrocarbonés et/ou siliconés. Dans le cas d'un mélange de différents corps gras pâteux, on utilise de préférence les composés pâteux hydrocarbonés (contenant principalement des atomes de carbone et d'hydrogène et éventuellement des groupements ester), en proportion majoritaire.More particularly, these fatty substances may be hydrocarbon compounds, optionally of polymeric type; they can also be chosen from silicone compounds; they may also be in the form of a mixture of hydrocarbon compounds and / or silicone. In the case of a mixture of different pasty fatty substances, use is preferably made of hydrocarbon-based pasty compounds (mainly containing carbon and hydrogen atoms and optionally ester groups), in majority proportion.
On peut aussi citer les corps gras pâteux siliconés tels que les polydiméthylsiloxanes (PDMS) de hauts poids moléculaires et en particulier ceux ayant des chaînes pendantes du type alkyle ou alcoxy ayant de 8 à 24 atomes de carbone, et un point de fusion de 20-550C, comme le stéaryl diméthicone notamment celui vendu par la société Dow Corning sous le nom commercial de DC 2503® Cosmetic Wax. Le corps gras pâteux peut être présent dans la composition selon l'invention en une teneur allant de 0,01 à 50% en poids, notamment allant de 0,1 à 45 % en poids, et en particulier allant de 0,2 à 30 % en poids par rapport au poids total de la composition.Mention may also be made of silicone pasty fatty substances such as polydimethylsiloxanes (PDMS) of high molecular weight and in particular those having pendent chains of the alkyl or alkoxy type having from 8 to 24 carbon atoms, and a melting point of 20- 55 0 C, such as stearyl dimethicone, in particular that sold by Dow Corning under the trade name DC 2503 ® Cosmetic Wax. The pasty fatty substance may be present in the composition according to the invention in a content ranging from 0.01 to 50% by weight, in particular ranging from 0.1 to 45% by weight, and in particular ranging from 0.2 to 30% by weight relative to the total weight of the composition.
La composition selon l'invention peut comprendre en outre une cire.The composition according to the invention may further comprise a wax.
La cire peut être solide à température ambiante (200C), à changement d'état solide/liquide réversible, ayant une température de fusion supérieure à 300C pouvant aller jusqu'à 2000C, une dureté supérieure à 0,5 MPa et présentant à l'état solide une organisation cristalline anisotrope. Elle peut être hydrocarbonée, fluorée et/ou siliconée et être d'origine animale, végétale, minérale ou synthétique. Elle peut être choisie par exemple parmi la cire d'abeille, la cire de Carnauba, la cire de Candellila, les cires de paraffine, l'huile de ricin hydrogénée, les cires de silicone, et les cires microcristallines et leurs mélanges.The wax may be solid at ambient temperature (20 ° C.), with reversible solid / liquid state change, having a melting point of greater than 30 ° C. and up to 200 ° C., a hardness of greater than 0.5 MPa and having in the solid state an anisotropic crystalline organization. It can be hydrocarbon, fluorinated and / or silicone and be of animal, vegetable, mineral or synthetic origin. It may be chosen for example from beeswax, carnauba wax, candelilla wax, paraffin waxes, hydrogenated castor oil, silicone waxes, and microcrystalline waxes and mixtures thereof.
La cire peut être présente dans la composition selon l'invention en une teneur allant de 0,01 à 50 % en poids, en particulier de 0,1 à 30 % en poids, et notamment de 0,2 à 20 % en poids, par rapport au poids total de la composition.The wax may be present in the composition according to the invention in a content ranging from 0.01 to 50% by weight, in particular from 0.1 to 30% by weight, and especially from 0.2 to 20% by weight, relative to the total weight of the composition.
La composition selon l'invention peut en outre contenir des agents tensioactifs émulsionnants présents notamment en une proportion allant deThe composition according to the invention may further contain emulsifying surfactants present in particular in a proportion ranging from
0,1 à 30 % en poids, et en particulier de 1 à 15 % en poids par rapport au poids total de la composition.0.1 to 30% by weight, and in particular 1 to 15% by weight relative to the total weight of the composition.
Ces agents tensioactifs peuvent être choisis parmi des agents tensioactifs anioniques, cationiques, amphotères ou non ioniques. On peut se reporter au document «Encyclopédie of Chemical Technology, KIRK-These surfactants may be chosen from anionic, cationic, amphoteric or nonionic surfactants. Reference can be made to the document "Encyclopedia of Chemical Technology, KIRK-
OTHMER», volume 22, p.333-432, 3ème édition, 1979, WILEY, pour la définition des propriétés et des fonctions (émulsionnant) des tensioactifs, en particulier p.347-377 de cette référence. pour_Jes tensioactifs. anioniques et non-ioniques.Othmer ", Volume 22, p.333-432, 3rd edition, 1979, Wiley, for the definition of the properties and functions (emulsifying) of surfactants, in particular p.347-377 this reference. for my surfactants. anionic and nonionic.
En particulier, les tensioactifs utilisés dans la composition selon l'invention sont choisis parmi les tensioactifs non-ioniques tels que les dérivés d'acides gras et d'alcools gras et les dérivés glycolysés. La composition de l'invention, peut en outre comprendre une phase particulaire additionnelle pouvant être présente à raison de 0,01 à 40 % en poids, notamment de 0,01 à 30 % en poids et en particulier de 0,05 à 20 % en poids, par rapport au poids total de la composition. Elle peut notamment comprendre au moins un pigment et/ou au moins une nacre et/ou au moins une charge complémentaire utilisés dans les compositions cosmétiques. Par pigments, il faut comprendre des particules blanches ou colorées, minérales ou organiques, insolubles dans la phase hydrophile liquide, destinées à colorer et/ou opacifier la composition. Par nacres, il faut comprendre des particules irisées et/ou colorées, obtenues principalement par synthèse. Par charges, il faut comprendre des particules incolores ou blanches, minérales ou de synthèse, lamellaires ou non lamellaires.In particular, the surfactants used in the composition according to the invention are chosen from nonionic surfactants such as derivatives of fatty acids and fatty alcohols and glycolized derivatives. The composition of the invention may further comprise an additional particulate phase which may be present in a proportion of from 0.01 to 40% by weight, in particular from 0.01 to 30% by weight and in particular from 0.05 to 20% by weight. by weight, relative to the total weight of the composition. It may in particular comprise at least one pigment and / or at least one nacre and / or at least one additional filler used in the cosmetic compositions. By pigments, it is necessary to understand white or colored particles, mineral or organic, insoluble in the liquid hydrophilic phase, intended to color and / or opacify the composition. By nacres, it is necessary to understand iridescent and / or colored particles, obtained mainly by synthesis. By charges, it is necessary to include colorless or white, mineral or synthetic, lamellar or non-lamellar particles.
Comme pigments minéraux utilisables dans l'invention, on peut citer les oxydes de titane, de zirconium ou de cérium ainsi que les oxydes de zinc, de fer ou de chrome.As inorganic pigments that may be used in the invention, mention may be made of titanium, zirconium or cerium oxides as well as oxides of zinc, iron or chromium.
Parmi les pigments organiques utilisables dans l'invention, on peut citer notamment les pigments de type D & C et les laques sur support baryum, strontium, calcium, ou aluminium. La quantité et/ou le choix de ces pigments sont généralement ajustés en prenant en compte la destination de la composition.Among the organic pigments that can be used in the invention, particular mention may be made of D & C type pigments and lacquers on a barium, strontium, calcium or aluminum support. The quantity and / or the choice of these pigments are generally adjusted taking into account the destination of the composition.
Les nacres peuvent être présentes dans la composition à raison de 0,01 à 25 % en poids, notamment de 0,01 à 15 % en poids, et en particulier de 0,02 à 5 % en poids par rapport au poids total de la composition.The nacres may be present in the composition in a proportion of from 0.01 to 25% by weight, especially from 0.01 to 15% by weight, and in particular from 0.02 to 5% by weight relative to the total weight of the composition. composition.
Les nacres peuvent être chpjsies_parmL les mica-titanes (mica recouvert par du dioxide de titane), les nacres colorées telles que le mica avec des oxydes de fer.Nacres can be used as mica-titanium (mica coated with titanium dioxide), colored nacres such as mica with iron oxides.
Les charges complémentaires peuvent être présentes à raison de 0,01 à 40 % en poids, notamment 0,01 à 30 % en poids, et en particulier de 0,02 à 20 % en poids par rapport au poids total de la composition. II peut notamment s'agir de charges éventuellement sphériques comme par exemple le talc, le stéarate de zinc, le mica, le kaolin, les poudres de polyamide (Nylon®) (Orgasol®), les poudres de polyéthylène, les poudres de polymères de méthyl méthacrylate (methyl methacrylate crosspolymer), les poudres de polymères de tétrafluoroéthylène (Téflon®), l'amidon, le nitrure de bore, des microsphéres polymériques telles que celles de chlorure de polyvinylidène/acrylonitrile comme l'Expancel®, copolymères d'acide acrylique (Polytrap® de la société Dow Corning), les microbilles de résine de silicone (Tospearls® de Toshiba, par exemple), et les organopolysiloxanes élastomères.The additional fillers may be present in a proportion of from 0.01 to 40% by weight, in particular from 0.01 to 30% by weight, and in particular from 0.02 to 20% by weight relative to the total weight of the composition. It may in particular be possibly spherical fillers such as, for example, talc, zinc stearate, mica, kaolin, polyamide (Nylon ® ) powders (Orgasol ® ), polyethylene powders, polyvinyl powders, methyl methacrylate (methyl methacrylate crosspolymer), tetrafluoroethylene polymer powders (Teflon ®), starch, boron nitride, polymer microspheres such as those of polyvinylidene chloride / acrylonitrile, for instance Expancel ®, copolymers of acrylic (Polytrap ® from Dow Corning) and silicone resin microbeads (Tospearls ® from Toshiba, for example), and organopolysiloxane elastomers.
La composition peut comprendre également des colorants hydrosolubles ou liposolubles en une teneur allant de 0,01 à 6 % en poids, notamment allant de 0,01 à 3 % en poids par rapport au poids total de la composition. Les colorants liposolubles sont par exemple le rouge Soudan, le DC Red 17, le DC Green 6, le carotène, l'huile de soja, le brun Soudan, le DC Yellow 11 , le DC Violet 2, le DC orange 5, et le jaune quinoléine. Les colorants hydrosolubles sont par exemple le jus de betterave et le FD&C blue i .The composition may also comprise water-soluble or fat-soluble dyes in a content ranging from 0.01 to 6% by weight, especially ranging from 0.01 to 3% by weight relative to the total weight of the composition. Liposoluble dyes are, for example, Sudan red, DC Red 17, DC Green 6, carotene, soybean oil, Sudan brown, DC Yellow 11, DC Violet 2, DC orange 5, and yellow quinoline. The water-soluble dyes are, for example, beet juice and FD & C blue i.
La composition selon l'invention peut, de plus, comprendre tous les ingrédients classiquement utilisés dans les domaines concernés et plus spécialement dans le domaine cosmétique et/ou dermatologique. Ces ingrédients sont en particulier choisis parmi les vitamines et les dérivés, les antioxydants, les épaississants, les oligo-éléments, les adoucissants, les séquestrants, les parfums, les agents alcalinisants ou acidifiants, les conservateurs, les filtres UV, les huiles.essentiellesτ les actifs hydrophiles ou lipophiles et leurs mélanges. Les quantités de ces différents ingrédients sont celles classiquement utilisées dans les domaines concernés et par exemple de 0,01 à 20 % du poids total de la composition. Bien entendu, grâce à ses connaissances, l'homme du métier veillera à choisir ce ou ces éventuels composés complémentaires, et/ou leur quantité, de manière telle que les propriétés avantageuses de la composition selon l'invention ne soient pas, ou substantiellement pas, altérées par l'adjonction considérée.The composition according to the invention may, moreover, comprise all the ingredients conventionally used in the fields concerned and more particularly in the cosmetic and / or dermatological field. These ingredients are in particular chosen from vitamins and derivatives, antioxidants, thickeners, trace elements, softeners, sequestering agents, perfumes, alkalizing or acidifying agents, preservatives, UV filters, essential oils. τ hydrophilic or lipophilic active agents and mixtures thereof. The amounts of these various ingredients are those conventionally used in the fields concerned and for example from 0.01 to 20% of the total weight of the composition. Of course, thanks to his knowledge, the person skilled in the art will take care to choose this or these optional complementary compounds, and / or their amount, such that the advantageous properties of the composition according to the invention are not, or not substantially impaired by the addition considered.
La composition selon l'invention peut être obtenue selon les procédés de préparation classiquement utilisés en cosmétique et/ou en dermatologie.The composition according to the invention can be obtained according to the preparation methods conventionally used in cosmetics and / or in dermatology.
Avantageusement, la composition selon l'invention est sous forme d'une émulsion H/E. Elle peut également se présenter sous la forme d'un produit coulé en stick, en pot ou en coupelle comme les rouges à lèvres ou les baumes à lèvres, les fonds de teint coulés, les produits anti-cernes, les « correcteursAdvantageously, the composition according to the invention is in the form of an O / W emulsion. It can also be in the form of a product cast in a stick, in a pot or in a dish such as lipsticks or lip balms, cast foundations, concealer products, "correctors"
» et/ou « embellisseurs » de teint et les fards à paupières ou à joues, d'un produit compacté. La composition selon l'invention peut tout particulièrement être une composition de soin pour la peau en particulier le visage, les lèvres, le contour des yeux, le cou, le corps et/ou le cuir chevelu et/ou les phanères en particulier les poils, les cils, les sourcils, les ongles et/ou les cheveux.And / or "beautifiers" of complexion and eyeshadows or cheeks, a compacted product. The composition according to the invention may especially be a care composition for the skin, in particular the face, the lips, the eye contour, the neck, the body and / or the scalp and / or the dander, in particular the hairs. , eyelashes, eyebrows, nails and / or hair.
Ladite composition peut éventuellement comprendre au moins un système photoprotecteur.Said composition may optionally comprise at least one photoprotective system.
La composition selon l'invention peut également être une composition de protection solaire notamment pour la peau et/ou les phanères, comprenant un système photoprotecteur.The composition according to the invention may also be a sunscreen composition, in particular for the skin and / or integuments, comprising a photoprotective system.
Dans ces compositions, le système photoprotecteur peut être présent en une teneur allant de 0,1 à 40 % en poids, en particulier de 0,5 à 30 % en poids, voire de 1 à 20 % en poids, par rapport au_ poids total de la composition.In these compositions, the photoprotective system may be present in a content ranging from 0.1 to 40% by weight, in particular from 0.5 to 30% by weight, or even from 1 to 20% by weight, relative to the total weight. of the composition.
Ce système photoprotecteur peut comprendre au moins un filtre organique hydrophile, au moins un filtre organique lipophile et/ou au moins un pigment minéral. Les filtres peuvent être choisis parmi le sulfate de méthyle de N1 N, N-triméthyl [(oxo-2 bornylidène-3) méthyl]-4 anilinium ; l'homosalate (DCI) ; l'oxybenzone (DCI) ; l'acide 2-phényl-benzimidazol 5 sulfonique et ses sels de potassium, de sodium et de triéthanolamine ; le 3,3'-(1 ,4- phénylènediméthylène) bis (7,7-diméthyl-2-oxo-bicyclo-[2,2,1] hept-1- ylméthanesulfonique acide) et ses sels ; le 1-(4-tert-butylphényl)-3-(4- méthoxyphényl) propane-1 ,3-dione ; l'acide alpha-(oxo-2-bomylidène-3)- toluène-4-sulfonique et ses sels ; le 2-cyano- 3,3-diphényl-acide acrylique ; l'ester 2-éthylhexyl (octocrylène) ; le polymère de N-{(2 et 4)-[(2-oxoborn-3- ylidène)méthyl]-benzyl}acrylamide ; le méthoxycinnamate d'octyle ; éthyl-4- aminobenzoate éthoxylé (PEG-25 PABA) ; l'isopentyl-4-méthoxycinnamate (isoamyl p-méthoxycinnamate) ; le 2,4,6-trianilino-(p-carbo-2'éthylhexyl-1'- oxy)-1 ,3,5- triazine (octyl triazone) ; le phénol,2-(2H-benzotriazol-2-yl)-4- méthy l-6-(2-méthy l-3-( 1 ,3,3, 3-tétraméthy I- 1 -(triméthy Isily l)oxy)- disiloxanyl)propyl)) (drometrizole trisiloxane) ; l'acide benzoïque, 4,4-((6- (((1 ,1 -diméthyl)éthyl amino)carbonyl)phényl)amino) 1,3,5, -triazine -2,4- diyl)diimino)bis-,bis (2-éthylhexyl)ester) ; le 3-(4'-méthylbenzylidène)-d-1 camphre (4-méthylbenzylidene camphor) ; le 3-benzylidène camphre (3- benzylidene camphor) ; le 2-éthylhexyl salicylate (octyl-salicylate) ; le A- diméthyl-amino-benzoate d'éthyl-2-hexyle (octyl diméthyl PABA) ; l'acide 2- hydroxy-4-méthoxybenzophénone-5-sulfonique (benzophénone-5) et son sel de sodium ; le 2,2'-méthylène-bis-6-(2H-benzotriazol-2-yl)-4- (tétraméthyl-butyl)-1 ,1 ,3,3-phénol ; le sel monosodique de l'acide 2-2'-bis- (1 ,4-phénylène) 1 H-benzimiadazole-4,6-disulphonique ; le (1,3,5)-triazine- 2,4-bis ([4-(2-éthyl-hexyloxy)-2-hydroxy]phényl)-6-(4-méthoxyphényl) ; le diméthicqdiéthylbenza]malonate_ (N° CAS 2075.74-74-1 ) .; _ _le_jdioxide_ jde titane ; l'acide benzoïque,2-[-4-(diéthylamino)-2-hydroxybenzoyl]- .hexylester (nom INCI : Diéthylamino Hydroxybenzoyl Hexyl Benzoate; N° CAS 302776-68-7). La composition selon l'invention peut également comprendre au moins un agent de bronzage et/ou de brunissage artificiels de la peau (agents autobronzants), par exemple de la dihydroxyacétone (DHA).This photoprotective system may comprise at least one hydrophilic organic filter, at least one lipophilic organic filter and / or at least one mineral pigment. The filters may be chosen from N 1 N, N-trimethyl [(oxo-2-bornborn-3-yl) methyl] -4-anilinium methyl sulfate; homosalate (INN); oxybenzone (INN); 2-phenylbenzimidazol sulfonic acid and its potassium, sodium and triethanolamine salts; 3,3 '- (1,4-phenylenedimethylene) bis (7,7-dimethyl-2-oxo-bicyclo [2,2,1] hept-1-ylmethanesulfonic acid) and its salts; 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) propane-1,3-dione; alpha- (oxo-2-bomylidene-3) -toluene-4-sulfonic acid and its salts; 2-cyano-3,3-diphenyl acrylic acid; 2-ethylhexyl (octocrylene) ester; N - {(2 and 4) - [(2-oxoborn-3-ylidene) methyl] benzyl} acrylamide polymer; octyl methoxycinnamate; ethoxylated ethyl-4-aminobenzoate (PEG-25 PABA); isopentyl-4-methoxycinnamate (isoamyl p-methoxycinnamate); 2,4,6-trianilino- (p-carbo-2-ethylhexyl-1'-oxy) -1,3,5-triazine (octyl triazone); phenol, 2- (2H-benzotriazol-2-yl) -4-methyl-6- (2-methyl-3- (1,,3,3,3-tetramethyl) -1- (trimethylsilyl) oxy] disiloxanyl) propyl)) (drometrizole trisiloxane); benzoic acid, 4,4 - ((6- (((1,1-dimethyl) ethylamino) carbonyl) phenyl) amino) 1,3,5, -triazine-2,4-diyl) diimino) bis- bis (2-ethylhexyl) ester); 3- (4'-methylbenzylidene) -d-1 camphor (4-methylbenzylidene camphor); 3-benzylidene camphor (3-benzylidene camphor); 2-ethylhexyl salicylate (octyl salicylate); 2-ethylhexyl-N-dimethylamino-benzoate (octyl dimethyl PABA); 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid (benzophenone-5) and its sodium salt; 2,2'-methylene-bis-6- (2H-benzotriazol-2-yl) -4- (tetramethyl-butyl) -1,1,3,3-phenol; the monosodium salt of 2-2'-bis (1,4-phenylene) 1H-benzimiadazole-4,6-disulphonic acid; (1,3,5) -triazine-2,4-bis ([4- (2-ethylhexyloxy) -2-hydroxy] phenyl) -6- (4-methoxyphenyl); the diméthicqdiéthylbenza] malonate_ (CAS 2075 74-74-1.). the titanium dioxide; benzoic acid, 2 - [- 4- (diethylamino) -2-hydroxybenzoyl] -hexyl ester (INCI name: Diethylamino Hydroxybenzoyl Hexyl Benzoate, CAS No. 302776-68-7). The composition according to the invention may also comprise at least one agent for artificial tanning and / or browning of the skin (self-tanning agents), for example dihydroxyacetone (DHA).
La composition selon l'invention peut comprendre une teneur en agent de bronzage et/ou de brunissage artificiels de la peau allant de 0,1 à 15 % en poids, et notamment allant de 1 à 10 % en poids, par rapport au poids total de la composition.The composition according to the invention may comprise an artificial tanning agent and / or browning content of the skin ranging from 0.1 to 15% by weight, and especially ranging from 1 to 10% by weight, relative to the total weight. of the composition.
La composition de l'invention peut se présenter sous la forme d'un produit de soin et/ou de maquillage de la peau et/ou des phanères Elle peut également être intégrée à un protocole de soin en cabine.The composition of the invention may be in the form of a skincare and / or makeup product for the skin and / or integuments. It can also be incorporated into a cabin care protocol.
Elle peut aussi s'utiliser en soin de nuit en association avec un soin de jour. Le soin du jour peut être par exemple le produit « AII Day AII Year» commercialisé par la société C.F.E.B. Sisley.It can also be used in night care in combination with a day care. The care of the day may be for example the product "AII Day AII Year" marketed by the company C.F.E.B. Sisley.
La présente invention concerne encore un procédé de traitement cosmétique d'au moins une matière kératinique, notamment la peau et les phanères, comprenant l'application sur ladite matière d'une composition cosmétique selon l'invention. Ce procédé peut comprendre l'application de ladite composition au moins une fois par jour, le soir par exemple.The present invention also relates to a process for the cosmetic treatment of at least one keratin material, in particular the skin and the integuments, comprising the application to said material of a cosmetic composition according to the invention. This method may comprise the application of said composition at least once a day, for example in the evening.
Ce procédé peut également comprendre l'application de ladite composition, au moins une fois par jour, dans les deux à dix jours qui précèdent l'exposition au soleil, en particulier dans le cadre d'une action préventive et/ou de préparation de la peau à une exposition au soleil.This method may also comprise the application of said composition, at least once a day, in the two to ten days preceding exposure to the sun, in particular as part of a preventive action and / or preparation of the skin to sun exposure.
Selon un autre de ses aspects, la présente invention a également pour objet l'utilisation d'une combinaison de 4 extraits végétaux selon l'invention, lesdits extraits étant :According to another of its aspects, the subject of the present invention is also the use of a combination of 4 plant extracts according to the invention, said extracts being:
(a) un extrait végétal de l'espèce Oryza sativa L ou riz,(a) a plant extract of the species Oryza sativa L or rice,
(b) un extrait végétal de l'espèce Triticum monococcum L ou petit épeautre, (c) un extrait végétal de l'espèce Salix alba L. ou saule blanc, et(b) a plant extract of the species Triticum monococcum L or small spelled, (c) a plant extract of the species Salix alba L. or white willow, and
(d) un extrait végétal de l'espèce Physalis alkekengi L ou alkékenge, en tant qu'agent contre le vieillissement notamment en tant qu'agent réparateur et/ou agent protecteur dans une composition cosmétique et/ou dermatologique, de préférence cosmétique.(d) a plant extract of the species Physalis alkekengi L or alkekenge, as anti-aging agent, especially as a repairing agent and / or protective agent in a cosmetic and / or dermatological, preferably cosmetic, composition.
La présente invention concerne aussi l'utilisation d'une combinaison de 4 extraits végétaux selon l'invention, lesdits extraits étant :The present invention also relates to the use of a combination of 4 plant extracts according to the invention, said extracts being:
(a) un extrait végétal de l'espèce Oryza sativa L. ou riz,(a) a plant extract of the species Oryza sativa L. or rice,
(b) un extrait végétal de l'espèce Triticum monococcum L. ou petit épeautre, (c) un extrait végétal de l'espèce Salix alba L. ou saule blanc, et(b) a plant extract of the species Triticum monococcum L. or small spelled, (c) a plant extract of the species Salix alba L. or white willow, and
(d) un extrait végétal de l'espèce Physalis alkekengi L. ou alkékenge, pour la préparation d'une composition dermatologique destinée à prévenir ou à traiter le viellissement de la peau et/ou les phanères, notamment par une action réparatrice et/ou protectrice.(d) a plant extract of the species Physalis alkekengi L. or alkekenge, for the preparation of a dermatological composition intended to prevent or treat aging of the skin and / or superficial body growths, in particular by a restorative action and / or protective.
Brève description des figuresBrief description of the figures
La figure 1 représente une coupe histologique d'expiants de peau sans irradiation UVB et sans formule A ou B, observée au microscope (x 40) après une coloration de type Hématoxyline et Eosine.FIG. 1 represents a histological section of skin explants without UVB irradiation and without formula A or B, observed under a microscope (× 40) after Hematoxylin and Eosin staining.
La figure 2 représente une coupe histologique d'expiants de peau soumis aux irradiations UVB et sans formule A ou B, observée au microscope (x 40) après une coloration de type Hématoxyline et Eosine.FIG. 2 represents a histological section of skin explants subjected to UVB irradiations and without formula A or B, observed under a microscope (× 40) after Hematoxylin and Eosin staining.
La figure 3 représente une coupe histologique d'expiants de peau avec irradiations UVB et avec formule A, observée au microscope (x 40) après une coloration de type Hématoxyline et Eosine.FIG. 3 represents a histological section of skin explants with UVB irradiations and with formula A, observed under a microscope (× 40) after Hematoxylin and Eosin staining.
La figure 4 représente une coupe histologique d'expiants de peau avec irradiations UVB et avec formule B, observée au microscope (x 40) après une coloration de type Hématoxyline et Eosine. EXEMPLESFIG. 4 represents a histological section of skin explants with UVB irradiations and with formula B, observed under a microscope (× 40) after Hematoxylin and Eosin staining. EXAMPLES
Exemple 1 : Composition selon l'inventionExample 1 Composition according to the invention
Crème réparatrice et protectriceRestorative and protective cream
Figure imgf000026_0001
Figure imgf000027_0001
Figure imgf000026_0001
Figure imgf000027_0001
Les quantités indiquées sont données en pourcentage de poids par rapport au poids total de la composition. Mode opératoire :The amounts indicated are given as a percentage of weight relative to the total weight of the composition. Operating mode:
- Préparer la phase A et la chauffer jusqu'à 750C.- Prepare phase A and heat it up to 75 0 C.
- Préparer la phase B. Lorsqu'elle est homogène, l'ajouter à la phase A puis agiter modérément.- Prepare phase B. When homogeneous, add it to phase A and stir gently.
- Préparer la phase C dans le fondoir. - 5 min avant émulsion, introduire la phase D dans les phases A+B sous agitation.- Prepare phase C in the melter. - 5 min before emulsion, introduce the phase D in the phases A + B with stirring.
- Aspirer la phase C dans les phases A+B+D. Puis faire l'émulsion sous agitation très vive à 75°C. - Préparer la phase E sous agitatioin vive puis l'incorporer.- Aspirate phase C in phases A + B + D. Then make the emulsion with vigorous stirring at 75 ° C. - Prepare phase E under strong stirring then incorporate it.
- Commencer le refroidissement sous agitation lente.- Start the cooling with slow stirring.
- Préparer la phase F, puis l'incorporer à 400C.- Prepare phase F, then incorporate it at 40 ° C.
- Préparer la phase G, puis l'incorporer à 35°C.- Prepare phase G, then incorporate it at 35 ° C.
- Puis préparer la phase H et l'incorporer à 35°C. - Préparer la phase I, puis l'incorporer à 300C.- Then prepare phase H and incorporate it at 35 ° C. - Prepare phase I, then incorporate it at 30 ° C.
- Terminer le refroidissement jusqu'à 25°C sous agitation lente.- Finish cooling to 25 ° C with slow stirring.
EXEMPLE 2 : Etudes ex vivo de l'effet réparateur et protecteur d'une crème selon l'invention comprenant la combinaison des quatre extraits végétauxEXAMPLE 2 Ex Vivo Studies of the Repairing and Protective Effect of a Cream According to the Invention Comprising the Combination of the Four Vegetable Extracts
Support Biopsies de 6 mm prélevées sur une femme âgée de 49 ans.Support Biopsies of 6 mm taken from a woman aged 49 years.
Produits testésProducts tested
Formule A (composition selon l'invention) : Formule complète avec la combinaison des quatre extraits végétauxFormula A (composition according to the invention): Complete formula with the combination of the four plant extracts
Formule B (Placebo) : Formule complète sans la combinaison des quatre extraits végétauxFormula B (Placebo): Complete formula without the combination of the four plant extracts
Mode opératoire Les biopsies ou explants de peau ont été maintenus en contact (au niveau de l'épiderme) avec 20μL des formules A et B, pendant 24h. Ces mêmes explants ont alors été soumis à des irradiations UVB à une dose de 100mJ/cm2, puis à nouveau maintenu en contact avec 20μL des formules A et B, pendant 24h.Procedure The skin biopsies or explants were kept in contact (at the level of the epidermis) with 20μL of the formulas A and B, during 24 hours. These same explants were then subjected to UVB irradiation at a dose of 100 mJ / cm 2 , then again kept in contact with 20 μl of formulas A and B for 24 hours.
Après ces 48h, des coupes histologiques ont été réalisées à partir de ces biopsies, et observées au microscope (x40) après une coloration de type Hématoxyline et Eosine.After these 48 hours, histological sections were made from these biopsies, and observed under a microscope (x40) after Hematoxylin and Eosin staining.
Description des étudesDescription of studies
Etude 1 : Etude « contrôle négatif » (explants de peau sans irradiations UVB et sans formule A ou B)Study 1: Study "negative control" (skin explants without irradiation UVB and without formula A or B)
Etude 2 : Etude « contrôle positif » (explants de peau soumis aux irradiations UVB et sans formule A ou B)Study 2: "Positive control" study (skin explants exposed to UVB irradiation and without formula A or B)
Etude 3 : Etude de l'effet de la composition cosmétique contenant la combinaison des quatre extraits végétaux (explants de peau avec irradiations UVB et avec formule A)Study 3: Study of the effect of the cosmetic composition containing the combination of the four plant extracts (skin explants with UVB irradiation and with formula A)
Etude 4 : Etude de l'effet « placebo » (explants de peau avec irradiations UVB et avec formule B)Study 4: Study of the "placebo" effect (skin explants with UVB irradiation and with formula B)
Observations et résultatsObservations and results
Etude 1 (Cf Figure 1) : Peau sans altération ni signe de dégénérescence^Study 1 (See Figure 1): Skin without alteration or sign of degeneration
Etude 2 (Cf Figure 2) : Peau présentant des signes de dégénérescence caractéristiques des dommages dus aux UVB (« sun burn cells » et vacuoles) Etude 3 (Cf Figure 3) : Peau présentant peu de signe de dégénérescence caractéristiques des dommages dus aux UVB (« sun burn cells » et vacuoles)Study 2 (See Figure 2): Skin showing signs of degeneration characteristic of UVB damage ("sun burn cells" and vacuoles) Study 3 (See Figure 3): Skin with little sign of degeneration characteristic of UVB damage ("sun burn cells" and vacuoles)
Etude 4 (Cf Figure 4) : Peau présentant des signes de dégénérescence caractéristiques des dommages dus aux UVB (« sun burn cells » et vacuoles)Study 4 (See Figure 4): Skin showing signs of degeneration characteristic of UVB damage ("sun burn cells" and vacuoles)
Conclusion des étudesConclusion of studies
Après une agression d'origine extérieure notamment les rayonnemments UV, en particulier les UVB, les études révèlent que la peau de contrôle présente des signes habituels d'agression (vacuoles, « sun burn cells », et dégénérescence) (Cf Figure 2).After external aggression including UV radiation, especially UVB, studies reveal that the control skin has usual signs of aggression (vacuoles, sunburn cells, and degeneration) (see Figure 2).
A l'opposé, la peau traitée avec la formule A selon l'invention (Cf Figure 3), révèle une grande protection face à l'agression UVB. Cette peau a nettement moins de vacuoles, de « sun burn cells », et a conservé une morphologie normale. (Cf Figure 3 versus Figure 4),In contrast, the skin treated with formula A according to the invention (see FIG. 3) reveals a high level of protection against UVB aggression. This skin has significantly fewer vacuoles, sun burn cells, and has retained a normal morphology. (See Figure 3 versus Figure 4),
On peut estimer que la combinaison des quatre extraits végétaux a diminué d'environ 60% les dommages induits par les UVB (Cf Figure 3 versus Figure 2), ce qui confirme son effet réparateur et protecteur remarquable. Listes des référencesIt can be estimated that the combination of the four plant extracts decreased UVB-induced damage by approximately 60% (see Figure 3 versus Figure 2), which confirms its remarkable restorative and protective effect. List of references
[1] WO 2007/077318 [2] WO 2006/024790 [1] WO 2007/077318 [2] WO 2006/024790

Claims

REVENDICATIONS
1. Composition cosmétique et/ou dermatologique comprenant une combinaison de 4 extraits végétaux, lesdits extraits étant : (a) un extrait végétal de l'espèce Oryza sativa L. ou riz,Cosmetic and / or dermatological composition comprising a combination of 4 plant extracts, said extracts being: (a) a plant extract of the species Oryza sativa L. or rice,
(b) un extrait végétal de l'espèce Triticum monococcum L. ou petit épeautre,(b) a plant extract of the species Triticum monococcum L. or small spelled,
(c) un extrait végétal de l'espèce Salix alba L. ou saule blanc, et(c) a plant extract of the species Salix alba L. or white willow, and
(d) un extrait végétal de l'espèce Physalis alkekengi L. ou alkékenge.(d) a plant extract of the species Physalis alkekengi L. or alkekenge.
2. Composition selon la revendication 1, dans laquelle l'extrait végétal2. Composition according to claim 1, in which the plant extract
(a) est obtenu à partir des grains de riz.(a) is obtained from the grains of rice.
3. Composition selon l'une des revendications 1 ou 2, dans laquelle l'extrait végétal (b) est obtenu à partir des graines de petit épeautre.3. Composition according to one of claims 1 or 2, wherein the plant extract (b) is obtained from the seeds of small spelled.
4. Composition selon l'une quelconque des revendications 1 à 3, dans laquelle l'extrait végétal (c) est obtenu à partir des feuilles de saule blanc.4. Composition according to any one of claims 1 to 3, wherein the plant extract (c) is obtained from white willow leaves.
5. Composition selon l'une quelconque des revendications 1 à 4, dans laquelle l'extrait végétal (d) obtenu à partir de calices de physalis.5. Composition according to any one of claims 1 to 4, wherein the plant extract (d) obtained from calyxes of physalis.
6. Composition cosmétique et/ou dermatologique selon l'une quelconque des revendications 1 à 5 comprenant une combinaison de 4 extraits végétaux, lesdits extraits étant :6. Cosmetic and / or dermatological composition according to any one of claims 1 to 5 comprising a combination of 4 plant extracts, said extracts being:
(a) un extrait végétal de l'espèce Oryza sativa L. ou riz obtenu à partir des grains de riz,(a) a plant extract of the species Oryza sativa L. or rice obtained from the grains of rice,
(b) un extrait végétal de l'espèce Triticum monococcum L. ou petit épeautre obtenu à partir des graines de petit épeautre, (c) un extrait végétal de l'espèce Salix alba L. ou saule blanc obtenu à partir des feuilles de saule blanc, et (d) un extrait végétal de l'espèce Physalis alkekengi L ou alkékenge obtenu à partir de calices de physalis.(b) a plant extract of the species Triticum monococcum L. or small spelled obtained from the seeds of small spelled, (c) a plant extract of the species Salix alba L. or white willow obtained from the leaves of willow white, and (d) a plant extract of the species Physalis alkekengi L or alkekenge obtained from calyxes of physalis.
7. Composition selon l'une quelconque des revendications 1 à 6 comprenant une teneur en extrait de d'Oryza sativa L ou riz, allant de 0,1 à 20 % en poids par rapport au poids total de la composition.7. Composition according to any one of claims 1 to 6 comprising an extract content of Oryza sativa L or rice, ranging from 0.1 to 20% by weight relative to the total weight of the composition.
8. Composition selon l'une quelconque des revendications 1 à 7 comprenant une teneur en extrait de Triticum monococcum L. ou petit épeautre allant de 0,1 à 20 % en poids par rapport au poids total de la composition.8. Composition according to any one of claims 1 to 7 comprising an extract content of Triticum monococcum L. or small spelled from 0.1 to 20% by weight relative to the total weight of the composition.
9. Composition selon l'une quelconque des revendications 1 à 8 comprenant une teneur en extrait de Salix alba L ou saule blanc allant de 0,1 à 20 % en poids par rapport au poids total de la composition.9. Composition according to any one of claims 1 to 8 comprising an extract content of Salix alba L or white willow ranging from 0.1 to 20% by weight relative to the total weight of the composition.
10. Composition selon l'une quelconque des revendications comprenant une teneur en extrait de Physalis alkekengi L ou alkékenge allant de 0,1 à 20 % en poids par rapport au poids total de la composition.10. Composition according to any one of claims comprising an extract of Physalis alkekengi L or alkenkeng content ranging from 0.1 to 20% by weight relative to the total weight of the composition.
11. Composition selon l'une quelconque des revendications 1 à 10 sous forme d'une émulsion H/E.11. Composition according to any one of claims 1 to 10 in the form of an O / W emulsion.
12. Composition selon selon l'une quelconque des revendications 1 à 11, ladite composition étant sous la forme d'un produit de soin et/ou de rnaqujilage..djeja peau et/ou des phanères.^12. A composition according to any one of claims 1 to 11, said composition being in the form of a skincare product and / or skinned skin and / or superficial integuments.
13. Composition selon selon l'une quelconque des revendications 1 à 12, ladite composition étant une composition de protection solaire pour la peau et/ou les phanères, comprenant un système photoprotecteur. 13. Composition according to any one of claims 1 to 12, said composition being a sunscreen composition for the skin and / or superficial body growths, comprising a photoprotective system.
14. Composition selon l'une quelconque des revendications 1 à 13, ladite composition étant intégrée à un protocole de soin en cabine.14. Composition according to any one of claims 1 to 13, said composition being incorporated into a caring protocol in the cabin.
15. Utilisation d'une combinaison de 4 extraits végétaux , lesdits extraits étant :15. Use of a combination of 4 plant extracts, said extracts being:
(a) un extrait végétal de l'espèce Oryza sativa L ou riz,(a) a plant extract of the species Oryza sativa L or rice,
(b) un extrait végétal de l'espèce Triticυm monococcum L ou petit épeautre,(b) a plant extract of the species Triticum monococcum L or small spelled,
(c) un extrait végétal de l'espèce Salix alba L ou saule blanc, et (d) un extrait végétal de l'espèce Physalis alkekengi L. ou alkékenge, en tant qu'agent réparateur et/ou agent protecteur dans une composition cosmétique.(c) a plant extract of the species Salix alba L or white willow, and (d) a plant extract of the species Physalis alkekengi L. or alkekenge, as a repairing agent and / or protective agent in a cosmetic composition .
16. Utilisation d'une combinaison de 4 extraits végétaux , lesdits extraits étant :16. Use of a combination of 4 plant extracts, said extracts being:
(a) un extrait végétal de l'espèce Oryza sativa L ou riz,(a) a plant extract of the species Oryza sativa L or rice,
(b) un extrait végétal de l'espèce Triticum monococcum L ou petit épeautre,(b) a plant extract of the species Triticum monococcum L or small spelled,
(c) un extrait végétal de l'espèce Salix alba L. ou saule blanc, et (d) un extrait végétal de l'espèce Physalis alkekengi L. ou alkékenge, pour la préparation d'une composition dermatologique destinée à prévenir ou à traiter le viellissement de la peau et/ou les phanères, notamment par une action réparatrice et/ou protectrice.(c) a plant extract of the species Salix alba L. or white willow, and (d) a plant extract of the species Physalis alkekengi L. or alkekenge, for the preparation of a dermatological composition for preventing or treating the aging of the skin and / or the integuments, in particular by a restorative and / or protective action.
17. Procédé de traitement cosmétique d'au moins une matière kératinique, notamment la peau et les phanères, comprenant l'application sur ladite matière d'une composition cosmétique selon l'une quelconque des revendications 1 à 14. 17. A process for the cosmetic treatment of at least one keratin material, especially the skin and superficial body growths, comprising the application to said material of a cosmetic composition according to any one of claims 1 to 14.
PCT/FR2009/000617 2009-05-27 2009-05-27 Cosmetic and/or dermatological composition made from a combination of four plant extracts and the uses thereof WO2010136657A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/FR2009/000617 WO2010136657A1 (en) 2009-05-27 2009-05-27 Cosmetic and/or dermatological composition made from a combination of four plant extracts and the uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/FR2009/000617 WO2010136657A1 (en) 2009-05-27 2009-05-27 Cosmetic and/or dermatological composition made from a combination of four plant extracts and the uses thereof

Publications (1)

Publication Number Publication Date
WO2010136657A1 true WO2010136657A1 (en) 2010-12-02

Family

ID=41720528

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2009/000617 WO2010136657A1 (en) 2009-05-27 2009-05-27 Cosmetic and/or dermatological composition made from a combination of four plant extracts and the uses thereof

Country Status (1)

Country Link
WO (1) WO2010136657A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2985906A1 (en) * 2012-01-25 2013-07-26 Lvmh Rech Composition used e.g. as lipstick, mascara or foundation, and for preventing the appearance of signs of skin aging, comprises extract of white willow species of Salix alba and extract of vine species of Vitis vinifera
WO2015089385A1 (en) * 2013-12-12 2015-06-18 Kemin Industries, Inc. Personal care products containing extracts of chinese lantern (physalis alkekengi)
US20180193248A1 (en) * 2016-01-07 2018-07-12 Kemin Industries, Inc. Determination of melanin inhibition potential of natural ingredients

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003201229A (en) * 2001-10-23 2003-07-18 Shiseido Co Ltd Matrix metalloprotease activity inhibitor and ageing- resistant cosmetic
FR2873918A1 (en) * 2004-08-06 2006-02-10 Vincience Sa USE OF A TRITICUM MONOCOCCUM EXTRACT AS AN ACTIVE INGREDIENT IN A COSMETIC AND / OR PHARMACEUTICAL COMPOSITION
FR2896155A1 (en) * 2006-01-18 2007-07-20 C F E B Sisley Sa Cosmetic/dermatological composition, useful e.g. as anti-aging and/or anti-radicalizing agents to treat skin and hair, comprises a Physalis (ground cherry) calyx extract
FR2915383A1 (en) * 2007-04-27 2008-10-31 Vincience Sa Use of an active ingredient obtained from hydrolyzed rice, in a cosmetic composition or for preparing pharmaceutical composition comprising active ingredient or composition to increase cellular energy and protect skin from oxidative damage

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003201229A (en) * 2001-10-23 2003-07-18 Shiseido Co Ltd Matrix metalloprotease activity inhibitor and ageing- resistant cosmetic
FR2873918A1 (en) * 2004-08-06 2006-02-10 Vincience Sa USE OF A TRITICUM MONOCOCCUM EXTRACT AS AN ACTIVE INGREDIENT IN A COSMETIC AND / OR PHARMACEUTICAL COMPOSITION
FR2896155A1 (en) * 2006-01-18 2007-07-20 C F E B Sisley Sa Cosmetic/dermatological composition, useful e.g. as anti-aging and/or anti-radicalizing agents to treat skin and hair, comprises a Physalis (ground cherry) calyx extract
FR2915383A1 (en) * 2007-04-27 2008-10-31 Vincience Sa Use of an active ingredient obtained from hydrolyzed rice, in a cosmetic composition or for preparing pharmaceutical composition comprising active ingredient or composition to increase cellular energy and protect skin from oxidative damage

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Rice extract stimulates collagen synthesis and displays an antiaging effect", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, C.V. MOSBY, ST. LOUIS, MO, US, vol. 58, no. 2, 1 February 2008 (2008-02-01), pages AB26, XP022456896, ISSN: 0190-9622 *
DATABASE WPI Week 200377, Derwent World Patents Index; AN 2003-819640, XP002571833 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2985906A1 (en) * 2012-01-25 2013-07-26 Lvmh Rech Composition used e.g. as lipstick, mascara or foundation, and for preventing the appearance of signs of skin aging, comprises extract of white willow species of Salix alba and extract of vine species of Vitis vinifera
WO2015089385A1 (en) * 2013-12-12 2015-06-18 Kemin Industries, Inc. Personal care products containing extracts of chinese lantern (physalis alkekengi)
CN105979955A (en) * 2013-12-12 2016-09-28 凯敏工业公司 Personal care products containing extracts of Chinese lantern (physalis alkekengi)
US20180193248A1 (en) * 2016-01-07 2018-07-12 Kemin Industries, Inc. Determination of melanin inhibition potential of natural ingredients

Similar Documents

Publication Publication Date Title
EP3576713B1 (en) Solid water-in-oil cosmetic emulsion
EP3174603B1 (en) Camellia japonica extract and cosmetic compositions thereof
EP1731136A1 (en) Cosmetic composition containing hollow organosilicon particles
EP1870076A2 (en) Solid emulsion with liquid oil phase structured by a polymer
EP3207920A1 (en) Use of active agents for increasing the ceramide content of the lips, as a protection agent for fragile lips
FR2907010A1 (en) COSMETIC COMPOSITION COMPRISING ELASTOMERS
FR2908982A1 (en) Cosmetic composition for making up and caring for skin, lips and keratin fibres, comprises one or more aprotic hydrocarbon-based volatile solvent comprising not more than one branch, in physiologically acceptable medium
FR2992173A1 (en) COSMETIC HEALING PROCESS FOR SKIN AND / OR LIP
WO2018020165A1 (en) Cosmetic product for the lips in the form of a water-in-oil emulsion and makeup method
FR2991870A1 (en) PROCESS FOR TREATING FAT SKIN
EP1925292A1 (en) Cosmetic composition comprising at least one volatile carbonic acid ester
EP1925291B1 (en) Cosmetic composition comprising at least one volatile ester
FR3044905B1 (en) USE OF ANTIOXIDANT TO DECREASE THE COLOR DEVELOPMENT OF BLACK POINTS
WO2010136657A1 (en) Cosmetic and/or dermatological composition made from a combination of four plant extracts and the uses thereof
FR2991583A1 (en) Composition, useful for minimizing skin irregularities such as wrinkles, pores and dark circles and redrawing the contours of the face, comprises extract of Rhus coriaria
EP1602353A1 (en) Make up cosmetic composition and/or lip care composition
FR3098108A1 (en) Long-lasting solid cosmetic composition
FR2851915A1 (en) Cosmetic make-up or care product for skin, hair or visible organs comprises dimer diol ester of monocarboxylic or dicarboxylic acid, semi-solid component and colorant
EP1238647A1 (en) Use of polyaminoacid derivatives as hydrating agents and cosmetic and pharmaceutical compositions containing them
WO2022223933A1 (en) Organic two-phase cosmetic composition with delayed phase separation
FR3007652A1 (en) COMPOSITION COMPRISING DOCOSAHEXAENOIC ACID AND PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE
FR2993775A1 (en) Cosmetic composition, useful for depigmenting skin exposed to sun, comprises a synergistic combination of a melanogenesis inhibitor of resorcinol, a stable antioxidant derived from oxidation of ascorbic acid and rhubarb root extract
FR3104976A1 (en) Retinol-based composition
FR3098107A1 (en) Solid cosmetic composition
FR2896155A1 (en) Cosmetic/dermatological composition, useful e.g. as anti-aging and/or anti-radicalizing agents to treat skin and hair, comprises a Physalis (ground cherry) calyx extract

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09748126

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09748126

Country of ref document: EP

Kind code of ref document: A1